kmdata rsupsup packag contain databas reconstruct patientlevel clinic trial dataset multipl surviv endpoint includ overal progressionfre surviv data extract kaplanmei km curv report oncolog phase iii clinic trial public studi identifi pubmedhttpspubmedncbinlmnihgov search clinic trial breast lung cancer prostat colorect cancer publish trial met search criteria extract curat studylevel inform report km surviv curv digit softwar digitizeithttpswwwdigitizeitd digit km surviv curv use estim possibl censor patientlevel event time use guyotalgorithmsupsup refer ida rcoreteam languag environ statist comput r found stat comput httpswwwrprojectorg ida guyot p ade ae ouwen mjnm welton nj enhanc secondari analysi surviv data reconstruct data publish kaplanmei surviv curv _bmc med re methodol_ doi instal r installpackagesdevtool devtoolsinstall_githubrareddkmdata build_vignett true get start view list data avail kmdata packag r datapackag kmdata gener individu patient data ipd digit surviv curv data use method describ guyot r librarysurviv sf survfitsurvtim statu cancer aa summarysf time pt ipdsftim sfsurv aatim aanrisk compar r sf call survfitformula survtim statu data cancer n event median lcl ucl r survfitsurvtim event pt call survfitformula survtim event data pt n event median lcl ucl addit resourc see kmdata intro vignettevignetteskmdataintrormd inform gener ipdvignetteskmdataipdrmd digit surviv curv titl kmdata intro output rmarkdownhtml_vignett toc true vignett vignetteindexentrykmdata intro vignetteengineknitrrmarkdown usepackageutfinputenc r includefals libraryknitr opts_chunkset cach fals figalign center dev png figwidth figheight echo true messag fals data set avail r librarykmdata datapackag kmdata show list data set avail data object refer attention_a tribe_a backtick data name special charact name consist studi shortnam figur identifi r data lspackagekmdata pattern az cbind name data studi gsub_ data figur gsub_ data exampl studi attent two figur b studi actscc one figur data set sourc multipanel figur name look similar studi attent figur id b data set list kmdata_key along use metadata includ journal public identifi outcom studi arm qualiti recapitul data inform work data data set contain format consist r echofals knitrkabl datafram time timetoev unit event event indic arm treatment arm identifi eg arm vs arm time unit event type treatment arm found help page data set eg act_a addit data object contain metadata store attribut r headact_a attract_a event attributesact_a data may examin plot use builtin function summari kmplot r figshowhold messag true summaryact_a kmplotact_a select data kmdata packag contain function select_kmdata easili search filter data set share common featur column kmdata_key may use filter exampl want list lung cancer data set overal surviv os month fewer patient report least hazard ratio treatment compar refer arm use follow r select_kmdata cancer lung outcom os unit month reportedsamples hazardratio return name default select_kmdata return name data set refer individu ie select_kmdata return name also return match row kmdata_key match data set list r figheight figwidth resultshid key select_kmdata cancer lung outcom os unit month reportedsamples hazardratio return key dat select_kmdata cancer lung outcom os unit month reportedsamples hazardratio return data parmfrow nmfrowlengthdat dd dat kmplotdd data qualiti figur data set contain qualiti score repres well recapitul agre origin public score rang worst best aggreg four metric hazard ratio total event median timetoev number atrisk metric score worst best maximum score per figur may vari metric report origin public exampl one report maximum score score point given per metric per figur recapitul metric differ publish point given metric differ point point differ differ public qualiti point per metric gt refer public figur avail packag list first author detail summaryclick expandsummari r echofals cit systemfiledoc citations_finalxlsx packag kmdata cit asdataframereadxlread_excelcit skip l cit withincit titl gsubssaz refer author gsub refer pubdata gsubaz sd refer journal gsubd pubdata year gsubd pubdata locat gsubd pubdata cpmid author journal year titl locat cit citordercitauthor rownamescit null knitrkablecit format markdown caption list public detail titl kmdata ipd output rmarkdownhtml_vignett toc true vignett vignetteindexentrykmdata ipd vignetteengineknitrrmarkdown usepackageutfinputenc r includefals libraryknitr opts_chunkset cach fals figalign center dev png figwidth figheight echo true messag fals gener ipd addit recapitul studi data kmdata packag contain algorithm recreat patientlevel timetoev data digit surviv curv digit curv simpli x ycoordin kaplanmei curv gener sever way includ coder packag digit proprietari softwar digitizeithttpsdigitizeitsoftcom r librarykmdata xy systemfil etc init checkmate__sa_nivolumabcsv packag kmdata ar systemfil etc init checkmate__at_riskcsv packag kmdata dd readcsvxi aa readcsvar aa aaaanrisk ipd ipdddt dd aatrisk aanrisk arm nivo kmplotipd confint fals median fals pointss dd type col red legend topright col lti bti n lwd legend crecapitul truth censoringndata avail refer guyot patricia et al enhanc secondari analysi surviv data reconstruct data publish kaplanmei surviv curv _bmc medic research methodology_ gener roxygen edit hand pleas edit document rdatar doctypedata namemarquee_a aliasmarquee_a titlemarque figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm erlotinib_placebo erlotinib_tivantinib cr sourc scagliotti g von pawel j novello et al phase iii multin random doubleblind placebocontrol studi tivantinib arq plu erlotinib versu erlotinib alon previous treat patient local advanc metastat nonsquam nonsmallcel lung cancer j clin oncol usag marquee_a descript kaplanmei digit data marque figur pmid report sampl size primari endpoint os lung cancer exampl summarymarquee_a kmplotmarquee_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_a aliasnct_a titlenct figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm control figitumumab cr sourc scagliotti gv bondarenko blackhal f et al random phase iii trial figitumumab combin erlotinib versu erlotinib alon patient nonadenocarcinoma nonsmallcel lung cancer ann oncol usag nct_a descript kaplanmei digit data nct figur pmid report sampl size primari endpoint os lung cancer exampl summarynct_a kmplotnct_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecalgb_b aliascalgb_b titlecalgb figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm placebo za cr sourc smith mr halabi ryan cj et al random control trial earli zoledron acid men castrationsensit prostat cancer bone metastas result calgb allianc j clin oncol usag calgb_b descript kaplanmei digit data calgb figur b pmid report sampl size primari endpoint time_sr prostat cancer exampl summarycalgb_b kmplotcalgb_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameaioa_c aliasaioa_c titleaioa figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm fu_bev no_tx cr sourc hegewischbeck graeven u lerchenm√ºl ca et al mainten strategi firstlin oxaliplatin plu fluoropyrimidin plu bevacizumab patient metastat colorect cancer aio randomis noninferior openlabel phase trial lancet oncol usag aioa_c descript kaplanmei digit data aioa figur c pmid report sampl size primari endpoint time_tx_failur colorect cancer exampl summaryaioa_c kmplotaioa_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameact_a aliasact_a titleact figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm amrubicin topotecan cr sourc von pawel j jott r spigel dr et al random phase iii trial amrubicin versu topotecan secondlin treatment patient smallcel lung cancer j clin oncol usag act_a descript kaplanmei digit data act figur pmid report sampl size primari endpoint os lung cancer exampl summaryact_a kmplotact_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebrec_a aliasbrec_a titlebrec figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm control experiment cr sourc moran wei j cobo et al two biomarkerdirect random trial european chines patient nonsmallcel lung cancer brcarap express custom brec studi ann oncol usag brec_a descript kaplanmei digit data brec figur pmid report sampl size primari endpoint pf lung cancer exampl summarybrec_a kmplotbrec_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecairo_d aliascairo_d titlecairo figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm mainten observ cr sourc simken lhj van tinteren h may et al mainten treatment capecitabin bevacizumab metastat colorect cancer cairo phase randomis control trial dutch colorect cancer group lancet usag cairo_d descript kaplanmei digit data cairo figur pmid report sampl size primari endpoint pf colorect cancer exampl summarycairo_d kmplotcairo_d keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namekeynote_a aliaskeynote_a titlekeynot figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm chemo pembrolizumab cr sourc reck rodr√≠guezabreu robinson ag et al pembrolizumab versu chemotherapi pdlposit nonsmallcel lung cancer n engl j med usag keynote_a descript kaplanmei digit data keynot figur pmid report sampl size primari endpoint pf lung cancer exampl summarykeynote_a kmplotkeynote_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_a aliasnct_a titlenct figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm gc gci cr sourc oshaughnessi j schwartzberg l danso et al phase iii studi iniparib plu gemcitabin carboplatin versu gemcitabin carboplatin patient metastat tripleneg breast cancer j clin oncol usag nct_a descript kaplanmei digit data nct figur pmid report sampl size primari endpoint ospf breast cancer exampl summarynct_a kmplotnct_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebebyp_ aliasbebyp_ titlebebyp figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm bev_ct ct cr sourc masi g salvator l boni l et al continu reintroduct bevacizumab beyond progress firstlin therapi metastat colorect cancer final result random bebyp trial ann oncol usag bebyp_ descript kaplanmei digit data bebyp figur pmid report sampl size primari endpoint pf colorect cancer exampl summarybebyp_ kmplotbebyp_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namechhipb_a aliaschhipb_a titlechhipb figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab rf event indic code event code event cr tab codearm tab treatment arm gy gy cr sourc dearnaley syndiku mossop h et al convent versu hypofraction highdos intensitymodul radiotherapi prostat cancer year outcom randomis noninferior phase chhip trial lancet oncol usag chhipb_a descript kaplanmei digit data chhipb figur pmid report sampl size primari endpoint brf prostat cancer exampl summarychhipb_a kmplotchhipb_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameinspire_a aliasinspire_a titleinspir figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm ct necitumumab_ct cr sourc pazar l mezger j ciuleanu te et al necitumumab plu pemetrex cisplatin firstlin therapi patient stage iv nonsquam nonsmallcel lung cancer inspir openlabel randomis control phase studi lancet oncol usag inspire_a descript kaplanmei digit data inspir figur pmid report sampl size primari endpoint os lung cancer exampl summaryinspire_a kmplotinspire_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namefire_a aliasfire_a titlefir figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm folfiri_bevacizumab folfiri_cetuximab cr sourc heinemann v von weikersth lf decker et al folfiri plu cetuximab versu folfiri plu bevacizumab firstlin treatment patient metastat colorect cancer fire randomis openlabel phase trial lancet oncol usag fire_a descript kaplanmei digit data fire figur pmid report sampl size primari endpoint objective_respons colorect cancer exampl summaryfire_a kmplotfire_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameprofile_a aliasprofile_a titleprofil figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm chemo crizotinib cr sourc solomon bj cappuzzo f felip e et al intracrani efficaci crizotinib versu chemotherapi patient advanc alkposit nonsmallcel lung cancer result profil j clin oncol usag profile_a descript kaplanmei digit data profil figur pmid report sampl size primari endpoint pf lung cancer exampl summaryprofile_a kmplotprofile_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameercc_d aliasercc_d titleercc figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm cisplatin p cr sourc lee sm falzon blackhal f et al random prospect biomark trial ercc compar platinum nonplatinum therapi advanc nonsmallcel lung cancer ercc trial et j clin oncol usag ercc_d descript kaplanmei digit data ercc figur pmid report sampl size primari endpoint os lung cancer exampl summaryercc_d kmplotercc_d keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namensabpr_b aliasnsabpr_b titlensabpr figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab lrr event indic code event code event cr tab codearm tab treatment arm no_oxali oxali cr sourc allegra cj yother g oconnel mj et al neoadjuv fu capecitabin plu radiat without oxaliplatin rectal cancer patient phase iii random clinic trial j natl cancer inst doijncidjv usag nsabpr_b descript kaplanmei digit data nsabpr figur b pmid report sampl size primari endpoint localregion tumor control colorect cancer exampl summarynsabpr_b kmplotnsabpr_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namelumelung_a aliaslumelung_a titlelumelung figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm docetaxel_nintedanib docetaxel_placebo cr sourc reck kaiser r mellemgaard et al docetaxel plu nintedanib versu docetaxel plu placebo patient previous treat nonsmallcel lung cancer lumelung phase doubleblind randomis control trial lancet oncol usag lumelung_a descript kaplanmei digit data lumelung figur pmid report sampl size primari endpoint pf lung cancer exampl summarylumelung_a kmplotlumelung_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameec_c aliasec_c titleec figur c format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm p cr sourc sparano ja zhao f martino et al longterm followup e phase iii trial evalu role taxan schedul oper breast cancer j clin oncol usag ec_c descript kaplanmei digit data ec figur c pmid report sampl size primari endpoint df breast cancer exampl summaryec_c kmplotec_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_a aliasnct_a titlenct figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cap eribulin cr sourc kaufman pa awada twelv c et al phase iii openlabel random studi eribulin mesyl versu capecitabin patient local advanc metastat breast cancer previous treat anthracyclin taxan j clin oncol usag nct_a descript kaplanmei digit data nct figur pmid report sampl size primari endpoint ospf breast cancer exampl summarynct_a kmplotnct_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namentr_ aliasntr_ titlentr figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm control thorac rt cr sourc slotman bj van tinteren h praag jo et al use thorac radiotherapi extens stage smallcel lung cancer phase randomis control trial lancet usag ntr_ descript kaplanmei digit data ntr figur pmid report sampl size primari endpoint osyr lung cancer exampl summaryntr_ kmplotntr_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameselectbc_a aliasselectbc_a titleselectbc figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm s_ taxan cr sourc takashima mukai h hara f et al taxan versu firstlin chemotherapi metastat breast cancer select bc openlabel noninferior randomis phase trial lancet oncol usag selectbc_a descript kaplanmei digit data selectbc figur pmid report sampl size primari endpoint os breast cancer exampl summaryselectbc_a kmplotselectbc_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecouaa_ aliascouaa_ titlecouaa figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm abirateron placebo cr sourc ryan cj smith mr fizazi k et al abirateron acet plu prednison versu placebo plu prednison chemotherapyna men metastat castrationresist prostat cancer couaa final overal surviv analysi randomis doubleblind placebocontrol phase studi lancet oncol usag couaa_ descript kaplanmei digit data couaa figur pmid report sampl size primari endpoint rpfso prostat cancer exampl summarycouaa_ kmplotcouaa_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namensabpb_ aliasnsabpb_ titlensabpb figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab ef event indic code event code event cr tab codearm tab treatment arm anastrazol tamoxifen cr sourc margoles rg cecchini rs julian tb et al anastrozol versu tamoxifen postmenopaus women ductal carcinoma situ undergo lumpectomi plu radiotherapi nsabp b randomis doubleblind phase clinic trial lancet usag nsabpb_ descript kaplanmei digit data nsabpb figur pmid report sampl size primari endpoint bcf breast cancer exampl summarynsabpb_ kmplotnsabpb_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameneoalttoa_a aliasneoalttoa_a titleneoalttoa figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab ef event indic code event code event cr tab codearm tab treatment arm l cr sourc de azambuja e holm ap piccartgebhart et al lapatinib trastuzumab herposit earli breast cancer neoaltto surviv outcom randomis openlabel multicentr phase trial associ patholog complet respons lancet oncol usag neoalttoa_a descript kaplanmei digit data neoalttoa figur pmid report sampl size primari endpoint pcr breast cancer exampl summaryneoalttoa_a kmplotneoalttoa_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebeacon_a aliasbeacon_a titlebeacon figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm control etirinotecan_pegol cr sourc perez ea awada oshaughnessi j et al etirinotecan pegol nktr versu treatment physician choic women advanc breast cancer previous treat anthracyclin taxan capecitabin beacon randomis openlabel multicentr phase trial lancet oncol usag beacon_a descript kaplanmei digit data beacon figur pmid report sampl size primari endpoint os breast cancer exampl summarybeacon_a kmplotbeacon_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameconcur_a aliasconcur_a titleconcur figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm placebo regorafenib cr sourc li j qin xu r et al regorafenib plu best support care versu placebo plu best support care asian patient previous treat metastat colorect cancer concur randomis doubleblind placebocontrol phase trial lancet oncol usag concur_a descript kaplanmei digit data concur figur pmid report sampl size primari endpoint os colorect cancer exampl summaryconcur_a kmplotconcur_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameaura_a aliasaura_a titleaura figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm osimertinib platinumpemetrex cr sourc mok ts wu yl ahn mj et al osimertinib platinumpemetrex egfr tmposit lung cancer n engl j med usag aura_a descript kaplanmei digit data aura figur pmid report sampl size primari endpoint pf lung cancer exampl summaryaura_a kmplotaura_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameint_a aliasint_a titleint figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm tamoxifen tamoxifen_of cr sourc tevaarwerk aj wang zhao f et al phase iii comparison tamoxifen versu tamoxifen plu ovarian function suppress premenopaus women nodeneg hormon receptorposit breast cancer e int trial eastern cooper oncolog group j clin oncol usag int_a descript kaplanmei digit data int figur pmid report sampl size primari endpoint dfso breast cancer exampl summaryint_a kmplotint_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameextenet_a aliasextenet_a titleextenet figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm neratinib placebo cr sourc chan delalog holm fa et al neratinib trastuzumabbas adjuv therapi patient herposit breast cancer extenet multicentr randomis doubleblind placebocontrol phase trial lancet oncol usag extenet_a descript kaplanmei digit data extenet figur pmid report sampl size primari endpoint idf breast cancer exampl summaryextenet_a kmplotextenet_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameeagle_ aliaseagle_ titleeagl figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm bev bev cr sourc iwamoto takahashi tamagawa h et al folfiri plu bevacizumab secondlin therapi patient metastat colorect cancer firstlin bevacizumab plu oxaliplatinbas therapi random phase iii eagl studi ann oncol usag eagle_ descript kaplanmei digit data eagl figur pmid report sampl size primari endpoint pf colorect cancer exampl summaryeagle_ kmploteagle_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecairo_a aliascairo_a titlecairo figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm mainten observ cr sourc simken lhj van tinteren h may et al mainten treatment capecitabin bevacizumab metastat colorect cancer cairo phase randomis control trial dutch colorect cancer group lancet usag cairo_a descript kaplanmei digit data cairo figur pmid report sampl size primari endpoint pf colorect cancer exampl summarycairo_a kmplotcairo_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namema_ aliasma_ titlema figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm ltax_l ttax_t cr sourc gelmon ka boyl fm kaufman b et al lapatinib trastuzumab plu taxan therapi human epiderm growth factor receptor posit advanc breast cancer final result ncic ctg j clin oncol usag ma_ descript kaplanmei digit data figur pmid report sampl size primari endpoint pf breast cancer exampl summaryma_ kmplotma_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametribe_b aliastribe_b titletrib figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm folfiri_bevacizumab folfoxiri_bevacizumab cr sourc loupaki f cremolini c masi g et al initi therapi folfoxiri bevacizumab metastat colorect cancer n engl j med usag tribe_b descript kaplanmei digit data tribe figur b pmid report sampl size primari endpoint pf colorect cancer exampl summarytribe_b kmplottribe_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecalgb_b aliascalgb_b titlecalgb figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm nab_paclitaxel p cr sourc rugo hs barri wt morenoaspitia et al random phase iii trial paclitaxel per week compar nanoparticl albuminbound nabpaclitaxel per week ixabepilon bevacizumab firstlin chemotherapi local recurr metastat breast cancer calgb ncctg nh allianc j clin oncol usag calgb_b descript kaplanmei digit data calgb figur b pmid report sampl size primari endpoint pf breast cancer exampl summarycalgb_b kmplotcalgb_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namegim_b aliasgim_b titlegim figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm ec_p fec_p cr sourc del mastro l de placido bruzzi p et al fluorouracil dosedens chemotherapi adjuv treatment patient earlystag breast cancer openlabel factori randomis phase trial lancet usag gim_b descript kaplanmei digit data gim figur b pmid report sampl size primari endpoint df breast cancer exampl summarygim_b kmplotgim_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemetlung_a aliasmetlung_a titlemetlung figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm onaturzumab_erlotinib placebo_erlotinib cr sourc spigel dr edelman mj obyrn k et al result phase iii random trial onartuzumab plu erlotinib versu erlotinib previous treat stage iiib iv nonsmallcel lung cancer metlung j clin oncol usag metlung_a descript kaplanmei digit data metlung figur pmid report sampl size primari endpoint os lung cancer exampl summarymetlung_a kmplotmetlung_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametribe_ aliastribe_ titletrib figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm folfiri_bev folfoxiri_bev cr sourc cremolini c loupaki f antoniotti c et al folfoxiri plu bevacizumab versu folfiri plu bevacizumab firstlin treatment patient metastat colorect cancer updat overal surviv molecular subgroup analys openlabel phase tribe studi lancet oncol usag tribe_ descript kaplanmei digit data tribe figur pmid report sampl size primari endpoint pf colorect cancer exampl summarytribe_ kmplottribe_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameomega_a aliasomega_a titleomega figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm cap peg_doxorubicin cr sourc smorenburg ch de groot sm van leeuwenstok ae et al random phase iii studi compar pegyl liposom doxorubicin capecitabin firstlin chemotherapi elderli patient metastat breast cancer result omega studi dutch breast cancer research group boog ann oncol usag omega_a descript kaplanmei digit data omega figur pmid report sampl size primari endpoint pf breast cancer exampl summaryomega_a kmplotomega_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameazure_ aliasazure_ titleazur figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm control zoledronic_acid cr sourc coleman r cameron dodwel et al adjuv zoledron acid patient earli breast cancer final efficaci analysi azur big randomis openlabel phase trial lancet oncol usag azure_ descript kaplanmei digit data azur figur pmid report sampl size primari endpoint df breast cancer exampl summaryazure_ kmplotazure_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametrapeze_a aliastrapeze_a titletrapez figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm no_za za cr sourc jame nd pirri sj pope et al clinic outcom surviv follow treatment metastat castraterefractori prostat cancer docetaxel alon strontium zoledron acid trapez random clinic trial jama oncol usag trapeze_a descript kaplanmei digit data trapez figur pmid report sampl size primari endpoint cpfscosteffect prostat cancer exampl summarytrapeze_a kmplottrapeze_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemagrit_a aliasmagrit_a titlemagrit figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm mage_a placebo cr sourc vansteenkist jf cho bc vanakesa et al efficaci magea cancer immunotherapeut adjuv therapi patient resect mageaposit nonsmallcel lung cancer magrit randomis doubleblind placebocontrol phase trial lancet oncol usag magrit_a descript kaplanmei digit data magrit figur pmid report sampl size primari endpoint df primari diff pop lung cancer exampl summarymagrit_a kmplotmagrit_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namedart_a aliasdart_a titledart figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm ltad stad cr sourc zapatero guerrero maldonado x et al highdos radiotherapi shortterm longterm androgen depriv localis prostat cancer dart gicor randomis control phase trial lancet oncol usag dart_a descript kaplanmei digit data dart figur pmid report sampl size primari endpoint bdf prostat cancer exampl summarydart_a kmplotdart_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenitro_a aliasnitro_a titlenitro figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm chemo nitro_chemo cr sourc davidson veillard tognela et al phase iii random trial ad topic nitroglycerin firstlin chemotherapi advanc nonsmallcel lung cancer australasian lung cancer trial group nitro trial ann oncol usag nitro_a descript kaplanmei digit data nitro figur pmid report sampl size primari endpoint pf lung cancer exampl summarynitro_a kmplotnitro_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameimpress_ aliasimpress_ titleimpress figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm gefitinib placebo cr sourc soria jc wu yl nakagawa k et al gefitinib plu chemotherapi versu placebo plu chemotherapi egfrmutationposit nonsmallcel lung cancer progress firstlin gefitinib impress phase randomis trial lancet oncol usag impress_ descript kaplanmei digit data impress figur pmid report sampl size primari endpoint pf lung cancer exampl summaryimpress_ kmplotimpress_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameproctorscript_a aliasproctorscript_a titleproctorscript figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm chemo observ cr sourc breugom aj van gijn w muller ew et al adjuv chemotherapi rectal cancer patient treat preoper chemoradiotherapi total mesorect excis dutch colorect cancer group dccg random phase iii trial ann oncol usag proctorscript_a descript kaplanmei digit data proctorscript figur pmid report sampl size primari endpoint os colorect cancer exampl summaryproctorscript_a kmplotproctorscript_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameact_a aliasact_a titleact figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm wt_b wt_be cr sourc hagman h fr√∂din je berglund √• et al random studi krasguid mainten therapi bevacizumab erlotinib metronom capecitabin firstlin induct treatment metastat colorect cancer nordic act trial ann oncol usag act_a descript kaplanmei digit data act figur pmid report sampl size primari endpoint pfsmo colorect cancer exampl summaryact_a kmplotact_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namesirflox_ aliassirflox_ titlesirflox figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm mfolfox mfolfox_rt cr sourc van hazel ga heinemann v sharma nk et al sirflox random phase iii trial compar firstlin mfolfox plu minu bevacizumab versu mfolfox plu minu bevacizumab plu select intern radiat therapi patient metastat colorect cancer j clin oncol usag sirflox_ descript kaplanmei digit data sirflox figur pmid report sampl size primari endpoint pf colorect cancer exampl summarysirflox_ kmplotsirflox_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_a aliasnct_a titlenct figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm mpt pt cr sourc baselga j manikha cort√© j et al phase iii trial nonpegyl liposom doxorubicin combin trastuzumab paclitaxel herposit metastat breast cancer ann oncol usag nct_a descript kaplanmei digit data nct figur pmid report sampl size primari endpoint pf breast cancer exampl summarynct_a kmplotnct_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameenestg_b aliasenestg_b titleenestg figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm imatinib nilotinib cr sourc blay jy shen l kang yk et al nilotinib versu imatinib firstlin therapi patient unresect metastat gastrointestin stromal tumour enestg randomis phase trial lancet oncol usag enestg_b descript kaplanmei digit data enestg figur b pmid report sampl size primari endpoint pf colorect cancer exampl summaryenestg_b kmplotenestg_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemar_b aliasmar_b titlemar figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm l placebo cr sourc goss pe ingl jn pritchard ki et al extend aromataseinhibitor adjuv therapi year n engl j med usag mar_b descript kaplanmei digit data mar figur b pmid report sampl size primari endpoint df breast cancer exampl summarymar_b kmplotmar_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameamaros_a aliasamaros_a titleamaro figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm dissect radiotherapi cr sourc donker van tienhoven g straver et al radiotherapi surgeri axilla posit sentinel node breast cancer eortc amaro randomis multicentr openlabel phase noninferior trial lancet oncol usag amaros_a descript kaplanmei digit data amaro figur pmid report sampl size primari endpoint axrecurrenceyr breast cancer exampl summaryamaros_a kmplotamaros_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namencicbr_b aliasncicbr_b titlencicbr figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm dacomitinib placebo cr sourc elli pm shepherd fa millward et al dacomitinib compar placebo pretreat patient advanc metastat nonsmallcel lung cancer ncic ctg br doubleblind randomis phase trial lancet oncol usag ncicbr_b descript kaplanmei digit data ncicbr figur b pmid report sampl size primari endpoint os lung cancer exampl summaryncicbr_b kmplotncicbr_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namepaloma_a aliaspaloma_a titlepaloma figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm palbociclib_letrozol placebo_letrozol cr sourc finn rs martin rugo hs et al palbociclib letrozol advanc breast cancer n engl j med usag paloma_a descript kaplanmei digit data paloma figur pmid report sampl size primari endpoint pf breast cancer exampl summarypaloma_a kmplotpaloma_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namer_ aliasr_ titler figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm fulv fulv_cpt cr sourc delbaldo c ychou zawadi et al postop irinotecan resect stage iiiii rectal cancer final analysi french r intergroup trial ann oncol usag r_ descript kaplanmei digit data r figur pmid report sampl size primari endpoint df colorect cancer exampl summaryr_ kmplotr_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namejcog_b aliasjcog_b titlejcog figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm amrubicin_cisplatin irinotecan_cisplatin cr sourc satouchi kotani shibata et al phase iii studi compar amrubicin plu cisplatin irinotecan plu cisplatin treatment extensivediseas smallcel lung cancer jcog j clin oncol usag jcog_b descript kaplanmei digit data jcog figur b pmid report sampl size primari endpoint os lung cancer exampl summaryjcog_b kmplotjcog_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namechhipb_b aliaschhipb_b titlechhipb figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm gy gy cr sourc dearnaley syndiku mossop h et al convent versu hypofraction highdos intensitymodul radiotherapi prostat cancer year outcom randomis noninferior phase chhip trial lancet oncol usag chhipb_b descript kaplanmei digit data chhipb figur b pmid report sampl size primari endpoint brf prostat cancer exampl summarychhipb_b kmplotchhipb_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemariannea_a aliasmariannea_a titlemariannea figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm tdm trastuzumab_taxan cr sourc perez ea barrio c eiermann w et al trastuzumab emtansin without pertuzumab versu trastuzumab plu taxan human epiderm growth factor receptor posit advanc breast cancer primari result phase iii mariann studi j clin oncol usag mariannea_a descript kaplanmei digit data mariannea figur pmid report sampl size primari endpoint pf breast cancer exampl summarymariannea_a kmplotmariannea_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameprose_a aliasprose_a titlepros figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm chemo erlotinib cr sourc gregorc v novello lazzari c et al predict valu proteom signatur patient nonsmallcel lung cancer treat secondlin erlotinib chemotherapi prose biomarkerstratifi randomis phase trial lancet oncol usag prose_a descript kaplanmei digit data prose figur pmid report sampl size primari endpoint os lung cancer exampl summaryprose_a kmplotprose_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebeyond_a aliasbeyond_a titlebeyond figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm bev_cp placebo_cp cr sourc zhou c wu yl chen g et al beyond random doubleblind placebocontrol multicent phase iii studi firstlin carboplatinpaclitaxel plu bevacizumab placebo chines patient advanc recurr nonsquam nonsmallcel lung cancer j clin oncol usag beyond_a descript kaplanmei digit data beyond figur pmid report sampl size primari endpoint pf prostat cancer exampl summarybeyond_a kmplotbeyond_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameluxlung_a aliasluxlung_a titleluxlung figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm afatinib pemetrexedcisplatin cr sourc yang jch wu yl schuler et al afatinib versu cisplatinbas chemotherapi egfr mutationposit lung adenocarcinoma luxlung luxlung analysi overal surviv data two randomis phase trial lancet oncol usag luxlung_a descript kaplanmei digit data luxlung figur pmid report sampl size primari endpoint pf lung cancer exampl summaryluxlung_a kmplotluxlung_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameproclaim_a aliasproclaim_a titleproclaim figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm eto_ci pem_ci cr sourc senan brade wang lh et al proclaim random phase iii trial pemetrexedcisplatin etoposidecisplatin plu thorac radiat therapi follow consolid chemotherapi local advanc nonsquam nonsmallcel lung cancer j clin oncol usag proclaim_a descript kaplanmei digit data proclaim figur pmid report sampl size primari endpoint os lung cancer exampl summaryproclaim_a kmplotproclaim_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namekeynote_ aliaskeynote_ titlekeynot figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm chemo pembrolizumab cr sourc reck rodr√≠guezabreu robinson ag et al pembrolizumab versu chemotherapi pdlposit nonsmallcel lung cancer n engl j med usag keynote_ descript kaplanmei digit data keynot figur pmid report sampl size primari endpoint pf lung cancer exampl summarykeynote_ kmplotkeynote_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namechronicle_b aliaschronicle_b titlechronicl figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm capecitabine_oxaliplatin follow_up_onli cr sourc glynnejon r counsel n quirk p et al chronicl result randomis phase iii trial local advanc rectal cancer neoadjuv chemoradi randomis postop adjuv capecitabin plu oxaliplatin xelox versu control ann oncol usag chronicle_b descript kaplanmei digit data chronicl figur b pmid report sampl size primari endpoint df colorect cancer exampl summarychronicle_b kmplotchronicle_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameluxlung_a aliasluxlung_a titleluxlung figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm afatinib_paclitaxel chemo cr sourc schuler yang jch park k et al afatinib beyond progress patient nonsmallcel lung cancer follow chemotherapi erlotinibgefitinib afatinib phase iii random luxlung trial ann oncol usag luxlung_a descript kaplanmei digit data luxlung figur pmid report sampl size primari endpoint pf lung cancer exampl summaryluxlung_a kmplotluxlung_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecheckmate_a aliascheckmate_a titlecheckm figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm nivolumab cr sourc borghaei h pazar l horn l et al nivolumab versu docetaxel advanc nonsquam nonsmallcel lung cancer n engl j med usag checkmate_a descript kaplanmei digit data checkmat figur pmid report sampl size primari endpoint os lung cancer exampl summarycheckmate_a kmplotcheckmate_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameoptimox_b aliasoptimox_b titleoptimox figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm bev bev_erlotinib cr sourc tournigand c chibaudel b samson b et al bevacizumab without erlotinib mainten therapi patient metastat colorect cancer gercor dream optimox randomis openlabel phase trial lancet oncol usag optimox_b descript kaplanmei digit data optimox figur b pmid report sampl size primari endpoint pf colorect cancer exampl summaryoptimox_b kmplotoptimox_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namejcog_a aliasjcog_a titlejcog figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm amrubicin_cisplatin irinotecan_cisplatin cr sourc satouchi kotani shibata et al phase iii studi compar amrubicin plu cisplatin irinotecan plu cisplatin treatment extensivediseas smallcel lung cancer jcog j clin oncol usag jcog_a descript kaplanmei digit data jcog figur pmid report sampl size primari endpoint os lung cancer exampl summaryjcog_a kmplotjcog_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namepaloma_a aliaspaloma_a titlepaloma figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm palbociclib_fulvestr placebo_fulvestr cr sourc turner nc ro j andr√© f et al palbociclib hormonereceptorposit advanc breast cancer n engl j med usag paloma_a descript kaplanmei digit data paloma figur pmid report sampl size primari endpoint pf breast cancer exampl summarypaloma_a kmplotpaloma_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameitaca_a aliasitaca_a titleitaca figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm ct ct_b cr sourc passardi nanni tassinari et al effect bevacizumab ad standard chemotherapi metastat colorect cancer final result firstlin treatment itaca random clinic trial ann oncol usag itaca_a descript kaplanmei digit data itaca figur pmid report sampl size primari endpoint pf colorect cancer exampl summaryitaca_a kmplotitaca_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namensabpr_a aliasnsabpr_a titlensabpr figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm fu cape cr sourc allegra cj yother g oconnel mj et al neoadjuv fu capecitabin plu radiat without oxaliplatin rectal cancer patient phase iii random clinic trial j natl cancer inst doijncidjv usag nsabpr_a descript kaplanmei digit data nsabpr figur pmid report sampl size primari endpoint localregion tumor control colorect cancer exampl summarynsabpr_a kmplotnsabpr_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namealttoc_a aliasalttoc_a titlealttoc figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm l cr sourc piccartgebhart holm e baselga j et al adjuv lapatinib trastuzumab earli human epiderm growth factor receptor posit breast cancer result random phase iii adjuv lapatinib andor trastuzumab treatment optim trial j clin oncol usag alttoc_a descript kaplanmei digit data alttoc figur pmid report sampl size primari endpoint df breast cancer exampl summaryalttoc_a kmplotalttoc_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameaspecct_a aliasaspecct_a titleaspecct figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cetuximab panitumumab cr sourc price tj peeter kim tw et al panitumumab versu cetuximab patient chemotherapyrefractori wildtyp kra exon metastat colorect cancer aspecct randomis multicentr openlabel noninferior phase studi lancet oncol usag aspecct_a descript kaplanmei digit data aspecct figur pmid report sampl size primari endpoint os colorect cancer exampl summaryaspecct_a kmplotaspecct_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametribe_a aliastribe_a titletrib figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm folfiri_bevacizumab folfoxiri_bevacizumab cr sourc mayer rj van cutsem e falcon et al random trial ta refractori metastat colorect cancer n engl j med usag tribe_a descript kaplanmei digit data tribe figur pmid report sampl size primari endpoint pf colorect cancer exampl summarytribe_a kmplottribe_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameluxlung_a aliasluxlung_a titleluxlung figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm afatinib gemcitabine_cisplatin cr sourc wu yl zhou c hu cp et al afatinib versu cisplatin plu gemcitabin firstlin treatment asian patient advanc nonsmallcel lung cancer harbour egfr mutat luxlung openlabel randomis phase trial lancet oncol usag luxlung_a descript kaplanmei digit data luxlung figur pmid report sampl size primari endpoint pf lung cancer exampl summaryluxlung_a kmplotluxlung_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namealttob_a aliasalttob_a titlealttob figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm t_then_l cr sourc piccartgebhart holm e baselga j et al adjuv lapatinib trastuzumab earli human epiderm growth factor receptor posit breast cancer result random phase iii adjuv lapatinib andor trastuzumab treatment optim trial j clin oncol usag alttob_a descript kaplanmei digit data alttob figur pmid report sampl size primari endpoint df breast cancer exampl summaryalttob_a kmplotalttob_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namesakk_b aliassakk_b titlesakk figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm chemo_surgeri crt_surgeri cr sourc pless stupp r ri hb et al induct chemoradi stage iiian nonsmallcel lung cancer phase randomis trial lancet usag sakk_b descript kaplanmei digit data sakk figur b pmid report sampl size primari endpoint ef lung cancer exampl summarysakk_b kmplotsakk_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namensabpr_a aliasnsabpr_a titlensabpr figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab lrr event indic code event code event cr tab codearm tab treatment arm fu cape cr sourc allegra cj yother g oconnel mj et al neoadjuv fu capecitabin plu radiat without oxaliplatin rectal cancer patient phase iii random clinic trial j natl cancer inst doijncidjv usag nsabpr_a descript kaplanmei digit data nsabpr figur pmid report sampl size primari endpoint localregion tumor control colorect cancer exampl summarynsabpr_a kmplotnsabpr_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameelda_b aliaselda_b titleelda figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cmf wdocetaxel cr sourc perron f nuzzo f di rella f et al weekli docetaxel versu cmf adjuv chemotherapi older women earli breast cancer final result random phase iii elda trial ann oncol usag elda_b descript kaplanmei digit data elda figur b pmid report sampl size primari endpoint df breast cancer exampl summaryelda_b kmplotelda_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namewjogl_b aliaswjogl_b titlewjogl figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm erlotinib gefitinib cr sourc urata katakami n morita et al random phase iii studi compar gefitinib erlotinib patient previous treat advanc lung adenocarcinoma wjog l j clin oncol usag wjogl_b descript kaplanmei digit data wjogl figur b pmid report sampl size primari endpoint pf lung cancer exampl summarywjogl_b kmplotwjogl_b keyworddataset gener roxygen edit hand pleas edit document rutilsr nameselect_kmdata aliasselect_kmdata titleselect data set usag select_kmdata return cname key data argument iteman express evalu within codelinkkmdata_key codereportedsamples see exampl itemreturntyp object return one codenam default studi name match criteria codekey match row codekmdata_key codedata list data frame match descript select public data set base studi characterist includ outcom sampl size treatment arm journal diseas etc exampl nameskmdata_key select_kmdatareportedsamples select_kmdatagreplfolfiri arm outcom os select_kmdatareportedsamples cancer clungcolorect prostat get list data set l select_kmdatareportedsamples return data parmfrow nmfrowlengthl sapplyl kmplot gener roxygen edit hand pleas edit document rdatar doctypedata namensabpb_b aliasnsabpb_b titlensabpb figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm bev no_bev cr sourc bear hd tang g rastogi p et al neoadjuv plu adjuv bevacizumab earli breast cancer nsabp b nrg oncolog secondari outcom phase randomis control trial lancet oncol usag nsabpb_b descript kaplanmei digit data nsabpb figur b pmid report sampl size primari endpoint pcr breast cancer exampl summarynsabpb_b kmplotnsabpb_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemaps_c aliasmaps_c titlemap figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm pc pcb cr sourc zalcman g mazier j margeri j et al bevacizumab newli diagnos pleural mesothelioma mesothelioma avastin cisplatin pemetrex studi map randomis control openlabel phase trial lancet usag maps_c descript kaplanmei digit data map figur c pmid report sampl size primari endpoint os lung cancer exampl summarymaps_c kmplotmaps_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameluxbreast_ aliasluxbreast_ titleluxbreast figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm afatinib cr sourc harbeck n huang cs hurvitz et al afatinib plu vinorelbin versu trastuzumab plu vinorelbin patient heroverexpress metastat breast cancer progress one previou trastuzumab treatment luxbreast openlabel randomis phase trial lancet oncol usag luxbreast_ descript kaplanmei digit data luxbreast figur pmid report sampl size primari endpoint pf breast cancer exampl summaryluxbreast_ kmplotluxbreast_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namefalcon_ aliasfalcon_ titlefalcon figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm anastrazol fulvestr cr sourc robertson jfr bondarenko im trishkina e et al fulvestr mg versu anastrozol mg hormon receptorposit advanc breast cancer falcon intern randomis doubleblind phase trial lancet usag falcon_ descript kaplanmei digit data falcon figur pmid report sampl size primari endpoint pf breast cancer exampl summaryfalcon_ kmplotfalcon_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecheckmate_c aliascheckmate_c titlecheckm figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm nivolumab cr sourc borghaei h pazar l horn l et al nivolumab versu docetaxel advanc nonsquam nonsmallcel lung cancer n engl j med usag checkmate_c descript kaplanmei digit data checkmat figur c pmid report sampl size primari endpoint os lung cancer exampl summarycheckmate_c kmplotcheckmate_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameeb_a aliaseb_a titleeb figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm p cr sourc sparano ja zhao f martino et al longterm followup e phase iii trial evalu role taxan schedul oper breast cancer j clin oncol usag eb_a descript kaplanmei digit data eb figur pmid report sampl size primari endpoint df breast cancer exampl summaryeb_a kmploteb_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameluxbreast_ aliasluxbreast_ titleluxbreast figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm afatinib cr sourc harbeck n huang cs hurvitz et al afatinib plu vinorelbin versu trastuzumab plu vinorelbin patient heroverexpress metastat breast cancer progress one previou trastuzumab treatment luxbreast openlabel randomis phase trial lancet oncol usag luxbreast_ descript kaplanmei digit data luxbreast figur pmid report sampl size primari endpoint pf breast cancer exampl summaryluxbreast_ kmplotluxbreast_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametcog_b aliastcog_b titletcog figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm docetaxel_ci s_ci cr sourc kubota k sakai h katakami n et al random phase iii trial oral plu cisplatin versu docetaxel plu cisplatin japanes patient advanc nonsmallcel lung cancer tcog cat trial ann oncol usag tcog_b descript kaplanmei digit data tcog figur b pmid report sampl size primari endpoint os lung cancer exampl summarytcog_b kmplottcog_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namesakk_a aliassakk_a titlesakk figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab ef event indic code event code event cr tab codearm tab treatment arm chemo_surgeri crt_surgeri cr sourc pless stupp r ri hb et al induct chemoradi stage iiian nonsmallcel lung cancer phase randomis trial lancet usag sakk_a descript kaplanmei digit data sakk figur pmid report sampl size primari endpoint ef lung cancer exampl summarysakk_a kmplotsakk_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameeb_c aliaseb_c titleeb figur c format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm p cr sourc sparano ja zhao f martino et al longterm followup e phase iii trial evalu role taxan schedul oper breast cancer j clin oncol usag eb_c descript kaplanmei digit data eb figur c pmid report sampl size primari endpoint df breast cancer exampl summaryeb_c kmploteb_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemindact_d aliasmindact_d titlemindact figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm chemo no_chemotherapi cr sourc cardoso f vant veer lj bogaert j et al gene signatur aid treatment decis earlystag breast cancer n engl j med usag mindact_d descript kaplanmei digit data mindact figur pmid report sampl size primari endpoint dmf breast cancer exampl summarymindact_d kmplotmindact_d keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenoah_b aliasnoah_b titlenoah figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm chemo chemotherapy_trastuzumab cr sourc gianni l eiermann w semiglazov v et al neoadjuv adjuv trastuzumab patient herposit local advanc breast cancer noah followup randomis control superior trial parallel herneg cohort lancet oncol usag noah_b descript kaplanmei digit data noah figur b pmid report sampl size primari endpoint ef breast cancer exampl summarynoah_b kmplotnoah_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namencicbr_a aliasncicbr_a titlencicbr figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm dacomitinib placebo cr sourc elli pm shepherd fa millward et al dacomitinib compar placebo pretreat patient advanc metastat nonsmallcel lung cancer ncic ctg br doubleblind randomis phase trial lancet oncol usag ncicbr_a descript kaplanmei digit data ncicbr figur pmid report sampl size primari endpoint os lung cancer exampl summaryncicbr_a kmplotncicbr_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namencta_b aliasncta_b titlencta figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm arma armc cr sourc sclafani f kim ty cunningham et al random phase iiiii studi dalotuzumab combin cetuximab irinotecan chemorefractori kra wildtyp metastat colorect cancer j natl cancer inst djv usag ncta_b descript kaplanmei digit data ncta figur b pmid report sampl size primari endpoint pfso colorect cancer exampl summaryncta_b kmplotncta_b keyworddataset gener roxygen edit hand pleas edit document ripdr nameipd aliasipd titleipd usag ipd time prob tatrisk natrisk total na arm arm tau maxtatrisk argument itemtim probvector surviv time probabl itemtatrisk natriskvector atrisk time number atrisk itemtotalopt total number event itemarmopt arm label itemtaumaximum followup time descript gener individu patient data ipd digit surviv curv data use method describ guyot exampl dontrun xy systemfileetc init checkmat _sa_nivolumabcsv packag kmdata ar systemfileetc init riskcsv packag kmdata dd readcsvxi aa readcsvar aa aaaanrisk use full atrisk tabl data ipd ipdddt dd aatrisk aanrisk arm nivo kmplotipd xaxisat xlim c use atrisk tabl idx replaceseq_alongaatrisk nrowaa true ipd ipdddt dd aatriskidx aanriskidx arm nivo kmplotipd xaxisat xlim c use atrisk tabl idx replaceseq_alongaatrisk nrowaa true ipd ipdddt dd aatriskidx aanriskidx arm nivo kmplotipd xaxisat xlim c use atrisk tabl idx replaceseq_alongaatrisk nrowaa true ipd ipdddt dd aatriskidx aanriskidx arm nivo kmplotipd xaxisat xlim c refer guyot patricia et al enhanc secondari analysi surviv data reconstruct data publish kaplanmei surviv curv emphbmc medic research methodolog strong gener roxygen edit hand pleas edit document rdatar doctypedata namegim_a aliasgim_a titlegim figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm ec_p fec_p cr sourc del mastro l de placido bruzzi p et al fluorouracil dosedens chemotherapi adjuv treatment patient earlystag breast cancer openlabel factori randomis phase trial lancet usag gim_a descript kaplanmei digit data gim figur pmid report sampl size primari endpoint df breast cancer exampl summarygim_a kmplotgim_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecalgb_a aliascalgb_a titlecalgb figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm ixabepilon p cr sourc rugo hs barri wt morenoaspitia et al random phase iii trial paclitaxel per week compar nanoparticl albuminbound nabpaclitaxel per week ixabepilon bevacizumab firstlin chemotherapi local recurr metastat breast cancer calgb ncctg nh allianc j clin oncol usag calgb_a descript kaplanmei digit data calgb figur pmid report sampl size primari endpoint pf breast cancer exampl summarycalgb_a kmplotcalgb_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameturandot_b aliasturandot_b titleturandot figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm bev_capecitabin bev_paclitaxel cr sourc zielinski c l√°ng inbar et al bevacizumab plu paclitaxel versu bevacizumab plu capecitabin firstlin treatment herneg metastat breast cancer turandot primari endpoint result randomis openlabel noninferior phase trial lancet oncol usag turandot_b descript kaplanmei digit data turandot figur b pmid report sampl size primari endpoint os breast cancer exampl summaryturandot_b kmplotturandot_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameraise_b aliasraise_b titlerais figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm placebo_folfiri ramucirumab_folfiri cr sourc tabernero j yoshino cohn al et al ramucirumab versu placebo combin secondlin folfiri patient metastat colorect carcinoma progress firstlin therapi bevacizumab oxaliplatin fluoropyrimidin rais randomis doubleblind multicentr phase studi lancet oncol usag raise_b descript kaplanmei digit data rais figur b pmid report sampl size primari endpoint os colorect cancer exampl summaryraise_b kmplotraise_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemindact_f aliasmindact_f titlemindact figur f format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm chemo no_chemotherapi cr sourc cardoso f vant veer lj bogaert j et al gene signatur aid treatment decis earlystag breast cancer n engl j med usag mindact_f descript kaplanmei digit data mindact figur f pmid report sampl size primari endpoint dmf breast cancer exampl summarymindact_f kmplotmindact_f keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameca_ aliasca_ titleca figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm ipilimumab placebo cr sourc kwon ed drake cg scher hi et al ipilimumab versu placebo radiotherapi patient metastat castrationresist prostat cancer progress docetaxel chemotherapi ca multicentr randomis doubleblind phase trial lancet oncol usag ca_ descript kaplanmei digit data ca figur pmid report sampl size primari endpoint os prostat cancer exampl summaryca_ kmplotca_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameneoalttob_a aliasneoalttob_a titleneoalttob figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab ef event indic code event code event cr tab codearm tab treatment arm lapatinib_trastuzumab cr sourc de azambuja e holm ap piccartgebhart et al lapatinib trastuzumab herposit earli breast cancer neoaltto surviv outcom randomis openlabel multicentr phase trial associ patholog complet respons lancet oncol usag neoalttob_a descript kaplanmei digit data neoalttob figur pmid report sampl size primari endpoint pcr breast cancer exampl summaryneoalttob_a kmplotneoalttob_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameca_ aliasca_ titleca figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm b cr sourc love rr laudico av van dinh n et al time adjuv surgic oophorectomi menstrual cycl diseasefre overal surviv premenopaus women oper breast cancer j natl cancer inst djv usag ca_ descript kaplanmei digit data ca figur pmid report sampl size primari endpoint df breast cancer exampl summaryca_ kmplotca_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecomet_b aliascomet_b titlecomet figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm cabozantinib prednison cr sourc smith de bono j sternberg c et al phase iii studi cabozantinib previous treat metastat castrationresist prostat cancer comet j clin oncol usag comet_b descript kaplanmei digit data comet figur b pmid report sampl size primari endpoint os prostat cancer exampl summarycomet_b kmplotcomet_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namesoft_a aliassoft_a titlesoft figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm tamoxifen tamoxifen_o cr sourc franci pa regan mm fleme gf et al adjuv ovarian suppress premenopaus breast cancer n engl j med usag soft_a descript kaplanmei digit data soft figur pmid report sampl size primari endpoint df breast cancer exampl summarysoft_a kmplotsoft_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameffcd_sb aliasffcd_sb titleffcd figur sb format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm fu iri cr sourc aparicio lavauden phelip jm et al random phase iii trial elderli patient compar lvfu without irinotecan firstlin treatment metastat colorect cancer ffcd ann oncol usag ffcd_sb descript kaplanmei digit data ffcd figur sb pmid report sampl size primari endpoint pf colorect cancer exampl summaryffcd_sb kmplotffcd_sb keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameensure_a aliasensure_a titleensur figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm erlotinib gp cr sourc wu yl zhou c liam ck et al firstlin erlotinib versu gemcitabinecisplatin patient advanc egfr mutationposit nonsmallcel lung cancer analys phase iii random openlabel ensur studi ann oncol usag ensure_a descript kaplanmei digit data ensur figur pmid report sampl size primari endpoint pf lung cancer exampl summaryensure_a kmplotensure_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namewjogl_a aliaswjogl_a titlewjogl figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cisplatin_docetaxel nedaplatin_docetaxel cr sourc shukuya yamanaka seto et al nedaplatin plu docetaxel versu cisplatin plu docetaxel advanc relaps squamou cell carcinoma lung wjogl randomis openlabel phase trial lancet oncol usag wjogl_a descript kaplanmei digit data wjogl figur pmid report sampl size primari endpoint os lung cancer exampl summarywjogl_a kmplotwjogl_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameamaros_b aliasamaros_b titleamaro figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm dissect radiotherapi cr sourc donker van tienhoven g straver et al radiotherapi surgeri axilla posit sentinel node breast cancer eortc amaro randomis multicentr openlabel phase noninferior trial lancet oncol usag amaros_b descript kaplanmei digit data amaro figur b pmid report sampl size primari endpoint axrecurrenceyr breast cancer exampl summaryamaros_b kmplotamaros_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameensure_a aliasensure_a titleensur figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm erlotinib gp cr sourc wu yl zhou c liam ck et al firstlin erlotinib versu gemcitabinecisplatin patient advanc egfr mutationposit nonsmallcel lung cancer analys phase iii random openlabel ensur studi ann oncol usag ensure_a descript kaplanmei digit data ensur figur pmid report sampl size primari endpoint pf lung cancer exampl summaryensure_a kmplotensure_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namegetug_ aliasgetug_ titlegetug figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab rf event indic code event code event cr tab codearm tab treatment arm adt adt_d cr sourc fizazi k faivr l lesauni f et al androgen depriv therapi plu docetaxel estramustin versu androgen depriv therapi alon highrisk localis prostat cancer getug phase randomis control trial lancet oncol usag getug_ descript kaplanmei digit data getug figur pmid report sampl size primari endpoint rf prostat cancer exampl summarygetug_ kmplotgetug_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namerevel_ aliasrevel_ titlerevel figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm placebo_docetaxel ramucirumab_docetaxel cr sourc garon eb ciuleanu te arrieta et al ramucirumab plu docetaxel versu placebo plu docetaxel secondlin treatment stage iv nonsmallcel lung cancer diseas progress platinumbas therapi revel multicentr doubleblind randomis phase trial lancet usag revel_ descript kaplanmei digit data revel figur pmid report sampl size primari endpoint os lung cancer exampl summaryrevel_ kmplotrevel_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namevantage_ aliasvantage_ titlevantag figur format data frame observ variabl tabularll tab codetim tab event time week cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm placebo vorinostat cr sourc krug lm kindler hl calvert h et al vorinostat patient advanc malign pleural mesothelioma progress previou chemotherapi vantag phase doubleblind randomis placebocontrol trial lancet oncol usag vantage_ descript kaplanmei digit data vantag figur pmid report sampl size primari endpoint ossafeti lung cancer exampl summaryvantage_ kmplotvantage_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebolero_ aliasbolero_ titlebolero figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm eve_ex pbo_ex cr sourc piccart hortobagyi gn campon et al everolimu plu exemestan hormonereceptorposit human epiderm growth factor receptorneg advanc breast cancer overal surviv result bolero ann oncol usag bolero_ descript kaplanmei digit data bolero figur pmid report sampl size primari endpoint pf breast cancer exampl summarybolero_ kmplotbolero_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namequasar_b aliasquasar_b titlequasar figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cap cap_bev cr sourc kerr rs love segelov e et al adjuv capecitabin plu bevacizumab versu capecitabin alon patient colorect cancer quasar openlabel randomis phase trial lancet oncol usag quasar_b descript kaplanmei digit data quasar figur b pmid report sampl size primari endpoint df colorect cancer exampl summaryquasar_b kmplotquasar_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameluxlung_b aliasluxlung_b titleluxlung figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm afatinib_paclitaxel chemo cr sourc schuler yang jch park k et al afatinib beyond progress patient nonsmallcel lung cancer follow chemotherapi erlotinibgefitinib afatinib phase iii random luxlung trial ann oncol usag luxlung_b descript kaplanmei digit data luxlung figur b pmid report sampl size primari endpoint pf lung cancer exampl summaryluxlung_b kmplotluxlung_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namegecestroapbi_ aliasgecestroapbi_ titlegecestroapbi figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm apbi wbi cr sourc strnad v ott oj hildebrandt g et al year result acceler partial breast irradi use sole interstiti multicathet brachytherapi versu wholebreast irradi boost breastconserv surgeri lowrisk invas insitu carcinoma femal breast randomis phase noninferior trial lancet usag gecestroapbi_ descript kaplanmei digit data gecestroapbi figur pmid report sampl size primari endpoint lr breast cancer exampl summarygecestroapbi_ kmplotgecestroapbi_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namencta_a aliasncta_a titlencta figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm arma armc cr sourc sclafani f kim ty cunningham et al random phase iiiii studi dalotuzumab combin cetuximab irinotecan chemorefractori kra wildtyp metastat colorect cancer j natl cancer inst djv usag ncta_a descript kaplanmei digit data ncta figur pmid report sampl size primari endpoint pfso colorect cancer exampl summaryncta_a kmplotncta_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namedelta_b aliasdelta_b titledelta figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm erlotinib cr sourc kawaguchi ando asami k et al random phase iii trial erlotinib versu docetaxel second thirdlin therapi patient advanc nonsmallcel lung cancer docetaxel erlotinib lung cancer trial delta j clin oncol usag delta_b descript kaplanmei digit data delta figur b pmid report sampl size primari endpoint pf lung cancer exampl summarydelta_b kmplotdelta_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namesquire_b aliassquire_b titlesquir figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm gem_ci necitumumab_gem_ci cr sourc thatcher n hirsch fr luft av et al necitumumab plu gemcitabin cisplatin versu gemcitabin cisplatin alon firstlin therapi patient stage iv squamou nonsmallcel lung cancer squir openlabel randomis control phase trial lancet oncol usag squire_b descript kaplanmei digit data squir figur b pmid report sampl size primari endpoint os lung cancer exampl summarysquire_b kmplotsquire_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameproctorscript_b aliasproctorscript_b titleproctorscript figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm chemo observ cr sourc breugom aj van gijn w muller ew et al adjuv chemotherapi rectal cancer patient treat preoper chemoradiotherapi total mesorect excis dutch colorect cancer group dccg random phase iii trial ann oncol usag proctorscript_b descript kaplanmei digit data proctorscript figur b pmid report sampl size primari endpoint os colorect cancer exampl summaryproctorscript_b kmplotproctorscript_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameactscc_a aliasactscc_a titleactscc figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm s_ uft_lv cr sourc yoshida ishiguro ikejiri k et al adjuv chemotherapi stage iii colon cancer random phase iii studi actscc trial ann oncol usag actscc_a descript kaplanmei digit data actscc figur pmid report sampl size primari endpoint dfs_yr colorect cancer exampl summaryactscc_a kmplotactscc_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namertog_d aliasrtog_d titlertog figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm observ rt cr sourc mccormick b winter k hudi c et al rtog prospect random trial goodrisk ductal carcinoma situ compar radiotherapi observ j clin oncol usag rtog_d descript kaplanmei digit data rtog figur pmid report sampl size primari endpoint ilf breast cancer exampl summaryrtog_d kmplotrtog_d keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebebyp_ aliasbebyp_ titlebebyp figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm bev_ct ct cr sourc masi g salvator l boni l et al continu reintroduct bevacizumab beyond progress firstlin therapi metastat colorect cancer final result random bebyp trial ann oncol usag bebyp_ descript kaplanmei digit data bebyp figur pmid report sampl size primari endpoint pf colorect cancer exampl summarybebyp_ kmplotbebyp_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namequasar_a aliasquasar_a titlequasar figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm cap cap_bev cr sourc kerr rs love segelov e et al adjuv capecitabin plu bevacizumab versu capecitabin alon patient colorect cancer quasar openlabel randomis phase trial lancet oncol usag quasar_a descript kaplanmei digit data quasar figur pmid report sampl size primari endpoint df colorect cancer exampl summaryquasar_a kmplotquasar_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecalgb_c aliascalgb_c titlecalgb figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm placebo za cr sourc smith mr halabi ryan cj et al random control trial earli zoledron acid men castrationsensit prostat cancer bone metastas result calgb allianc j clin oncol usag calgb_c descript kaplanmei digit data calgb figur c pmid report sampl size primari endpoint time_sr prostat cancer exampl summarycalgb_c kmplotcalgb_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametania_ aliastania_ titletania figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm chem_bev chemo cr sourc von minckwitz g puglisi f cort j et al bevacizumab plu chemotherapi versu chemotherapi alon secondlin treatment patient herneg local recurr metastat breast cancer firstlin treatment bevacizumab plu chemotherapi tania openlabel randomis phase trial lancet oncol usag tania_ descript kaplanmei digit data tania figur pmid report sampl size primari endpoint pf breast cancer exampl summarytania_ kmplottania_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameint_b aliasint_b titleint figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm tamoxifen tamoxifen_of cr sourc tevaarwerk aj wang zhao f et al phase iii comparison tamoxifen versu tamoxifen plu ovarian function suppress premenopaus women nodeneg hormon receptorposit breast cancer e int trial eastern cooper oncolog group j clin oncol usag int_b descript kaplanmei digit data int figur b pmid report sampl size primari endpoint dfso breast cancer exampl summaryint_b kmplotint_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namelea_a aliaslea_a titlelea figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm et et_b cr sourc mart√≠n loibl von minckwitz g et al phase iii trial evalu addit bevacizumab endocrin therapi firstlin treatment advanc breast cancer letrozolefulvestr avastin lea studi j clin oncol usag lea_a descript kaplanmei digit data lea figur pmid report sampl size primari endpoint pf breast cancer exampl summarylea_a kmplotlea_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameact_d aliasact_d titleact figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm mut_b mut_c cr sourc hagman h fr√∂din je berglund √• et al random studi krasguid mainten therapi bevacizumab erlotinib metronom capecitabin firstlin induct treatment metastat colorect cancer nordic act trial ann oncol usag act_d descript kaplanmei digit data act figur pmid report sampl size primari endpoint pfsmo colorect cancer exampl summaryact_d kmplotact_d keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameelmpc_a aliaselmpc_a titleelmpc figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm orteronel placebo cr sourc saad f fizazi k jinga v et al orteronel plu prednison patient chemotherapyna metastat castrationresist prostat cancer elmpc doubleblind multicentr phase randomis placebocontrol trial lancet oncol usag elmpc_a descript kaplanmei digit data elmpc figur pmid report sampl size primari endpoint rpfso prostat cancer exampl summaryelmpc_a kmplotelmpc_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemetlung_a aliasmetlung_a titlemetlung figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm onaturzumab_erlotinib placebo_erlotinib cr sourc spigel dr edelman mj obyrn k et al result phase iii random trial onartuzumab plu erlotinib versu erlotinib previous treat stage iiib iv nonsmallcel lung cancer metlung j clin oncol usag metlung_a descript kaplanmei digit data metlung figur pmid report sampl size primari endpoint os lung cancer exampl summarymetlung_a kmplotmetlung_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameconcept_a aliasconcept_a titleconcept figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab ttf event indic code event code event cr tab codearm tab treatment arm co io cr sourc hochster hs grothey hart l et al improv time treatment failur intermitt oxaliplatin strategi result concept ann oncol usag concept_a descript kaplanmei digit data concept figur pmid report sampl size primari endpoint ttf colorect cancer exampl summaryconcept_a kmplotconcept_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namerose_a aliasrose_a titleros figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm pbo_doc ram_doc cr sourc mackey jr ramosvazquez lipatov et al primari result rosetrio random placebocontrol phase iii trial evalu addit ramucirumab firstlin docetaxel chemotherapi metastat breast cancer j clin oncol usag rose_a descript kaplanmei digit data rose figur pmid report sampl size primari endpoint pf breast cancer exampl summaryrose_a kmplotrose_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namensabpb_ aliasnsabpb_ titlensabpb figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm anastrazol tamoxifen cr sourc margoles rg cecchini rs julian tb et al anastrozol versu tamoxifen postmenopaus women ductal carcinoma situ undergo lumpectomi plu radiotherapi nsabp b randomis doubleblind phase clinic trial lancet usag nsabpb_ descript kaplanmei digit data nsabpb figur pmid report sampl size primari endpoint bcf breast cancer exampl summarynsabpb_ kmplotnsabpb_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameradiant_c aliasradiant_c titleradi figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm everolimu placebo cr sourc yao jc fazio n singh et al everolimu treatment advanc nonfunct neuroendocrin tumour lung gastrointestin tract radiant randomis placebocontrol phase studi lancet usag radiant_c descript kaplanmei digit data radiant figur c pmid report sampl size primari endpoint pf lungcolorect cancer exampl summaryradiant_c kmplotradiant_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namequartz_a aliasquartz_a titlequartz figur format data frame observ variabl tabularll tab codetim tab event time week cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm osc osc_wbrt cr sourc mulvenna p nankivel barton r et al dexamethason support care without whole brain radiotherapi treat patient nonsmal cell lung cancer brain metastas unsuit resect stereotact radiotherapi quartz result phase noninferior randomis trial lancet usag quartz_a descript kaplanmei digit data quartz figur pmid report sampl size primari endpoint qali lung cancer exampl summaryquartz_a kmplotquartz_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namepetacc_a aliaspetacc_a titlepetacc figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm folfox folfox_cetuximab cr sourc taieb j tabernero j mini e et al oxaliplatin fluorouracil leucovorin without cetuximab patient resect stage iii colon cancer petacc openlabel randomis phase trial lancet oncol usag petacc_a descript kaplanmei digit data petacc figur pmid report sampl size primari endpoint df colorect cancer exampl summarypetacc_a kmplotpetacc_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemindact_c aliasmindact_c titlemindact figur c format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm chemo no_chemotherapi cr sourc cardoso f vant veer lj bogaert j et al gene signatur aid treatment decis earlystag breast cancer n engl j med usag mindact_c descript kaplanmei digit data mindact figur c pmid report sampl size primari endpoint dmf breast cancer exampl summarymindact_c kmplotmindact_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_b aliasnct_b titlenct figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm mpt pt cr sourc baselga j manikha cort√© j et al phase iii trial nonpegyl liposom doxorubicin combin trastuzumab paclitaxel herposit metastat breast cancer ann oncol usag nct_b descript kaplanmei digit data nct figur b pmid report sampl size primari endpoint pf breast cancer exampl summarynct_b kmplotnct_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_a aliasnct_a titlenct figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm control figitumumab cr sourc langer cj novello park k et al random phase iii trial firstlin figitumumab combin paclitaxel carboplatin versu paclitaxel carboplatin alon patient advanc nonsmallcel lung cancer j clin oncol usag nct_a descript kaplanmei digit data nct figur pmid report sampl size primari endpoint os lung cancer exampl summarynct_a kmplotnct_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecerebel_b aliascerebel_b titlecerebel figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm lapatinib_cap trastuzumab_cap cr sourc pivot x manikha ≈ºurawski b et al cerebel egf phase iii random openlabel studi lapatinib plu capecitabin versu trastuzumab plu capecitabin patient human epiderm growth factor receptor posit metastat breast cancer j clin oncol usag cerebel_b descript kaplanmei digit data cerebel figur b pmid report sampl size primari endpoint incidence_cnsmet breast cancer exampl summarycerebel_b kmplotcerebel_b keyworddataset gener roxygen edit hand pleas edit document rplotr namekmplot aliaskmplot aliasplotkmdata titlekmplot usag kmplot x relevel fals col null plot true xlim null ylim null xaxisat null xlab null ylab null lr_test true test_detail true median true atrisk true marktim true titl null legend true methodplotkmdata x relevel fals col null plot true xlim null ylim null xaxisat null xlab null ylab null lr_test true test_detail true median true atrisk true marktim true titl null legend true argument itemxa data set class codekmdata ie one data set pkgkmdata packag altern data frame column time event arm itemaddit argument pass codelinksurvivalplotsurvfit codelinkplotdefault codelinkpar itemrelevellog codetru group order revers default arm alphabet order may desir placebo control arm itemcola vector color surviv curv recycl atrisk tabl median legend itemplotlog codetru km figur drawn itemxlim ylimx yaxi limit itemxaxisatxaxi posit tick atrisk tabl itemxlab ylabth x yaxi label itemlr_testlog codetru logrank test shown upper right corner figur itemtest_detailslog codetru test statist degre freedom ad pvalu logrank test itemmedianlog codetru median curv ad itematrisklog codetru atrisk tabl drawn plot itemmarktimepass codelinksurvivalplotsurvfit itemtitleopt titl plot default codeattrdata titl itemlegendlog codetru legend arm total event hazard ratio ad descript make kaplanmei plot data set exampl kmplotattention_a kmplot attention_a relevel true median fals col xaxisat equival survivalplotsurvfit survfitsurvtim event arm attention_a plot col marktim true kmplot use gener given proper data structur dat dataframetim amltim event amlstatu arm amlx kmplotdat gener roxygen edit hand pleas edit document rdatar doctypedata nameimelda_b aliasimelda_b titleimelda figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm bevacizumab bevacizumab_capecitabin cr sourc gligorov j doval bine j et al mainten capecitabin bevacizumab versu bevacizumab alon initi firstlin bevacizumab docetaxel patient herneg metastat breast cancer imelda randomis openlabel phase trial lancet oncol usag imelda_b descript kaplanmei digit data imelda figur b pmid report sampl size primari endpoint pf breast cancer exampl summaryimelda_b kmplotimelda_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebolero_b aliasbolero_b titlebolero figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm everolimu placebo cr sourc hurvitz sa andr f jiang z et al combin everolimu trastuzumab plu paclitaxel firstlin treatment patient herposit advanc breast cancer bolero phase randomis doubleblind multicentr trial lancet oncol usag bolero_b descript kaplanmei digit data bolero figur b pmid report sampl size primari endpoint pfsoveral hr popul breast cancer exampl summarybolero_b kmplotbolero_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebolero_ aliasbolero_ titlebolero figur format data frame observ variabl tabularll tab codetim tab event time week cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm eve_ex placebo cr sourc andr√© f oregan r ozguroglu et al everolimu women trastuzumabresist herposit advanc breast cancer bolero randomis doubleblind placebocontrol phase trial lancet oncol usag bolero_ descript kaplanmei digit data bolero figur pmid report sampl size primari endpoint pf breast cancer exampl summarybolero_ kmplotbolero_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_b aliasnct_b titlenct figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm control figitumumab cr sourc scagliotti gv bondarenko blackhal f et al random phase iii trial figitumumab combin erlotinib versu erlotinib alon patient nonadenocarcinoma nonsmallcel lung cancer ann oncol usag nct_b descript kaplanmei digit data nct figur b pmid report sampl size primari endpoint os lung cancer exampl summarynct_b kmplotnct_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namex_b aliasx_b titl figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm folfiri panitumumab_folfiri cr sourc peeter price tj cervant et al final result random phase studi folfiri panitumumab secondlin treatment metastat colorect cancer ann oncol usag x_b descript kaplanmei digit data figur b pmid report sampl size primari endpoint pfso colorect cancer exampl summaryx_b kmplotx_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namegeicam_b aliasgeicam_b titlegeicam figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm ec_t et_x cr sourc mart√≠n ruiz sim√≥n ruiz borrego et al epirubicin plu cyclophosphamid follow docetaxel versu epirubicin plu docetaxel follow capecitabin adjuv therapi nodeposit earli breast cancer result geicam studi j clin oncol usag geicam_b descript kaplanmei digit data geicam figur b pmid report sampl size primari endpoint idf breast cancer exampl summarygeicam_b kmplotgeicam_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namejcog_b aliasjcog_b titlejcog figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm combination_chemotherapi topotecan cr sourc goto k ohe shibata et al combin chemotherapi cisplatin etoposid irinotecan versu topotecan alon secondlin treatment patient sensit relaps smallcel lung cancer jcog multicentr openlabel randomis phase trial lancet oncol usag jcog_b descript kaplanmei digit data jcog figur b pmid report sampl size primari endpoint os lung cancer exampl summaryjcog_b kmplotjcog_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namex_b aliasx_b titl figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm folfiri panitumumab_folfiri cr sourc peeter price tj cervant et al final result random phase studi folfiri panitumumab secondlin treatment metastat colorect cancer ann oncol usag x_b descript kaplanmei digit data figur b pmid report sampl size primari endpoint pfso colorect cancer exampl summaryx_b kmplotx_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebrec_c aliasbrec_c titlebrec figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm control experiment cr sourc moran wei j cobo et al two biomarkerdirect random trial european chines patient nonsmallcel lung cancer brcarap express custom brec studi ann oncol usag brec_c descript kaplanmei digit data brec figur c pmid report sampl size primari endpoint pf lung cancer exampl summarybrec_c kmplotbrec_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameca_a aliasca_a titleca figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm ipilimumab placebo cr sourc beer tm kwon ed drake cg et al random doubleblind phase iii trial ipilimumab versu placebo asymptomat minim symptomat patient metastat chemotherapyna castrationresist prostat cancer j clin oncol usag ca_a descript kaplanmei digit data ca figur pmid report sampl size primari endpoint os prostat cancer exampl summaryca_a kmplotca_a keyworddataset gener roxygen edit hand pleas edit document rdatademor doctypedata namekmdata_demo aliaskmdata_demo titlecodekmdata demograph data format data frame observ variabl tabularll tab codepubl tab public identifi cr tab codetherapi tab therapi receiv cr tab codedescript tab addit inform codetherapi appropri cr tab codemedian age tab median age publicationtherapi cr tab codeag rang tab age rang publicationtherapi cr tab codesexmal tab number male publicationtherapi cr tab codesexfemal tab number femal publicationtherapi cr tab coderacewhit tab number whitecaucasian publicationtherapi cr tab coderaceoth tab number nonwhitecaucasian publicationtherapi cr tab codeecogp tab number patient ecog perform score publicationtherapi cr tab codeecogp tab number patient ecog perform score publicationtherapi cr tab codeecogp unknown tab number patient ecog perform score unknown publicationtherapi cr usag kmdata_demo descript demograph data set codekmdata packag treatment arm miss valu shown either public report number could infer avail inform seealso codelinkkmdata_key codelinkselect_kmdata codelinksummarykmdata keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namex_a aliasx_a titl figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm folfiri panitumumab_folfiri cr sourc peeter price tj cervant et al final result random phase studi folfiri panitumumab secondlin treatment metastat colorect cancer ann oncol usag x_a descript kaplanmei digit data figur pmid report sampl size primari endpoint pfso colorect cancer exampl summaryx_a kmplotx_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameaiob_c aliasaiob_c titleaiob figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm fu_bev bev cr sourc hegewischbeck graeven u lerchenm√ºl ca et al mainten strategi firstlin oxaliplatin plu fluoropyrimidin plu bevacizumab patient metastat colorect cancer aio randomis noninferior openlabel phase trial lancet oncol usag aiob_c descript kaplanmei digit data aiob figur c pmid report sampl size primari endpoint time_tx_failur colorect cancer exampl summaryaiob_c kmplotaiob_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namegim_c aliasgim_c titlegim figur c format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm q q cr sourc del mastro l de placido bruzzi p et al fluorouracil dosedens chemotherapi adjuv treatment patient earlystag breast cancer openlabel factori randomis phase trial lancet usag gim_c descript kaplanmei digit data gim figur c pmid report sampl size primari endpoint df breast cancer exampl summarygim_c kmplotgim_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecalgb_d aliascalgb_d titlecalgb figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm nab_paclitaxel p cr sourc rugo hs barri wt morenoaspitia et al random phase iii trial paclitaxel per week compar nanoparticl albuminbound nabpaclitaxel per week ixabepilon bevacizumab firstlin chemotherapi local recurr metastat breast cancer calgb ncctg nh allianc j clin oncol usag calgb_d descript kaplanmei digit data calgb figur pmid report sampl size primari endpoint pf breast cancer exampl summarycalgb_d kmplotcalgb_d keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameneoalttob_d aliasneoalttob_d titleneoalttob figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm lapatinib_trastuzumab cr sourc de azambuja e holm ap piccartgebhart et al lapatinib trastuzumab herposit earli breast cancer neoaltto surviv outcom randomis openlabel multicentr phase trial associ patholog complet respons lancet oncol usag neoalttob_d descript kaplanmei digit data neoalttob figur pmid report sampl size primari endpoint pcr breast cancer exampl summaryneoalttob_d kmplotneoalttob_d keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namegeicam_a aliasgeicam_a titlegeicam figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm ec_t et_x cr sourc mart√≠n ruiz sim√≥n ruiz borrego et al epirubicin plu cyclophosphamid follow docetaxel versu epirubicin plu docetaxel follow capecitabin adjuv therapi nodeposit earli breast cancer result geicam studi j clin oncol usag geicam_a descript kaplanmei digit data geicam figur pmid report sampl size primari endpoint idf breast cancer exampl summarygeicam_a kmplotgeicam_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namerose_c aliasrose_c titleros figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm pbo_doc ram_doc cr sourc mackey jr ramosvazquez lipatov et al primari result rosetrio random placebocontrol phase iii trial evalu addit ramucirumab firstlin docetaxel chemotherapi metastat breast cancer j clin oncol usag rose_c descript kaplanmei digit data rose figur c pmid report sampl size primari endpoint pf breast cancer exampl summaryrose_c kmplotrose_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namealttoa_b aliasalttoa_b titlealttoa figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm l_t cr sourc piccartgebhart holm e baselga j et al adjuv lapatinib trastuzumab earli human epiderm growth factor receptor posit breast cancer result random phase iii adjuv lapatinib andor trastuzumab treatment optim trial j clin oncol usag alttoa_b descript kaplanmei digit data alttoa figur b pmid report sampl size primari endpoint df breast cancer exampl summaryalttoa_b kmplotalttoa_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameprevail_b aliasprevail_b titleprevail figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm enzalutamid placebo cr sourc beer tm armstrong aj rathkopf de et al enzalutamid metastat prostat cancer chemotherapi n engl j med usag prevail_b descript kaplanmei digit data prevail figur b pmid report sampl size primari endpoint pfso prostat cancer exampl summaryprevail_b kmplotprevail_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_b aliasnct_b titlenct figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm control figitumumab cr sourc langer cj novello park k et al random phase iii trial firstlin figitumumab combin paclitaxel carboplatin versu paclitaxel carboplatin alon patient advanc nonsmallcel lung cancer j clin oncol usag nct_b descript kaplanmei digit data nct figur b pmid report sampl size primari endpoint os lung cancer exampl summarynct_b kmplotnct_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namelumelung_c aliaslumelung_c titlelumelung figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm docetaxel_nintedanib docetaxel_placebo cr sourc reck kaiser r mellemgaard et al docetaxel plu nintedanib versu docetaxel plu placebo patient previous treat nonsmallcel lung cancer lumelung phase doubleblind randomis control trial lancet oncol usag lumelung_c descript kaplanmei digit data lumelung figur c pmid report sampl size primari endpoint pf lung cancer exampl summarylumelung_c kmplotlumelung_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameffcd_sa aliasffcd_sa titleffcd figur sa format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm fu iri cr sourc aparicio lavauden phelip jm et al random phase iii trial elderli patient compar lvfu without irinotecan firstlin treatment metastat colorect cancer ffcd ann oncol usag ffcd_sa descript kaplanmei digit data ffcd figur sa pmid report sampl size primari endpoint pf colorect cancer exampl summaryffcd_sa kmplotffcd_sa keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecomet_a aliascomet_a titlecomet figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cabozantinib prednison cr sourc smith de bono j sternberg c et al phase iii studi cabozantinib previous treat metastat castrationresist prostat cancer comet j clin oncol usag comet_a descript kaplanmei digit data comet figur pmid report sampl size primari endpoint os prostat cancer exampl summarycomet_a kmplotcomet_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemarianneb_a aliasmarianneb_a titlemarianneb figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm tdm_pertuzumab trastuzumab_taxan cr sourc perez ea barrio c eiermann w et al trastuzumab emtansin without pertuzumab versu trastuzumab plu taxan human epiderm growth factor receptor posit advanc breast cancer primari result phase iii mariann studi j clin oncol usag marianneb_a descript kaplanmei digit data marianneb figur pmid report sampl size primari endpoint pf breast cancer exampl summarymarianneb_a kmplotmarianneb_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namealttoc_b aliasalttoc_b titlealttoc figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm l cr sourc piccartgebhart holm e baselga j et al adjuv lapatinib trastuzumab earli human epiderm growth factor receptor posit breast cancer result random phase iii adjuv lapatinib andor trastuzumab treatment optim trial j clin oncol usag alttoc_b descript kaplanmei digit data alttoc figur b pmid report sampl size primari endpoint df breast cancer exampl summaryalttoc_b kmplotalttoc_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameact_a aliasact_a titleact figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm amrubicin topotecan cr sourc von pawel j jott r spigel dr et al random phase iii trial amrubicin versu topotecan secondlin treatment patient smallcel lung cancer j clin oncol usag act_a descript kaplanmei digit data act figur pmid report sampl size primari endpoint os lung cancer exampl summaryact_a kmplotact_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemarquee_b aliasmarquee_b titlemarque figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm erlotinib_placebo erlotinib_tivantinib cr sourc scagliotti g von pawel j novello et al phase iii multin random doubleblind placebocontrol studi tivantinib arq plu erlotinib versu erlotinib alon previous treat patient local advanc metastat nonsquam nonsmallcel lung cancer j clin oncol usag marquee_b descript kaplanmei digit data marque figur b pmid report sampl size primari endpoint os lung cancer exampl summarymarquee_b kmplotmarquee_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameercc_b aliasercc_b titleercc figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm cisplatin_pemetrex p cr sourc lee sm falzon blackhal f et al random prospect biomark trial ercc compar platinum nonplatinum therapi advanc nonsmallcel lung cancer ercc trial et j clin oncol usag ercc_b descript kaplanmei digit data ercc figur b pmid report sampl size primari endpoint os lung cancer exampl summaryercc_b kmplotercc_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecairo_b aliascairo_b titlecairo figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm mainten observ cr sourc simken lhj van tinteren h may et al mainten treatment capecitabin bevacizumab metastat colorect cancer cairo phase randomis control trial dutch colorect cancer group lancet usag cairo_b descript kaplanmei digit data cairo figur b pmid report sampl size primari endpoint pf colorect cancer exampl summarycairo_b kmplotcairo_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namefire_b aliasfire_b titlefir figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm folfiri_bevacizumab folfiri_cetuximab cr sourc heinemann v von weikersth lf decker et al folfiri plu cetuximab versu folfiri plu bevacizumab firstlin treatment patient metastat colorect cancer fire randomis openlabel phase trial lancet oncol usag fire_b descript kaplanmei digit data fire figur b pmid report sampl size primari endpoint objective_respons colorect cancer exampl summaryfire_b kmplotfire_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameprofile_a aliasprofile_a titleprofil figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm chemo crizotinib cr sourc solomon bj mok kim dw et al firstlin crizotinib versu chemotherapi alkposit lung cancer n engl j med usag profile_a descript kaplanmei digit data profil figur pmid report sampl size primari endpoint pf lung cancer exampl summaryprofile_a kmplotprofile_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemrcrt_a aliasmrcrt_a titlemrcrt figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm control escal cr sourc dearnaley dp jovic g syndiku et al escalateddos versu controldos conform radiotherapi prostat cancer longterm result mrc rt randomis control trial lancet oncol usag mrcrt_a descript kaplanmei digit data mrcrt figur pmid report sampl size primari endpoint bpfso prostat cancer exampl summarymrcrt_a kmplotmrcrt_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namema_ aliasma_ titlema figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm ltax_l ttax_t cr sourc gelmon ka boyl fm kaufman b et al lapatinib trastuzumab plu taxan therapi human epiderm growth factor receptor posit advanc breast cancer final result ncic ctg j clin oncol usag ma_ descript kaplanmei digit data figur pmid report sampl size primari endpoint pf breast cancer exampl summaryma_ kmplotma_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemirox_b aliasmirox_b titlemirox figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm folfox folfox_folfiri cr sourc hebbar chibaudel b andr√© et al folfox versu sequenti dosedens folfox follow folfiri patient resect metastat colorect cancer mirox pragmat approach chemotherapi time periop postop chemotherapi openlabel random phase iii trial ann oncol usag mirox_b descript kaplanmei digit data mirox figur b pmid report sampl size primari endpoint dfsyr colorect cancer exampl summarymirox_b kmplotmirox_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_b aliasnct_b titlenct figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm placebo tasq cr sourc sternberg c armstrong pili r et al random doubleblind placebocontrol phase iii studi tasquinimod men metastat castrationresist prostat cancer j clin oncol usag nct_b descript kaplanmei digit data nct figur b pmid report sampl size primari endpoint rpf prostat cancer exampl summarynct_b kmplotnct_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemrcrt_c aliasmrcrt_c titlemrcrt figur c format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm control escal cr sourc dearnaley dp jovic g syndiku et al escalateddos versu controldos conform radiotherapi prostat cancer longterm result mrc rt randomis control trial lancet oncol usag mrcrt_c descript kaplanmei digit data mrcrt figur c pmid report sampl size primari endpoint bpfso prostat cancer exampl summarymrcrt_c kmplotmrcrt_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namexb_a aliasxb_a titleb figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm control pci cr sourc li n zeng zf wang sy et al random phase iii trial prophylact cranial irradi versu observ patient fulli resect stage iiian nonsmallcel lung cancer high risk cerebr metastas adjuv chemotherapi ann oncol usag xb_a descript kaplanmei digit data b figur pmid report sampl size primari endpoint df lung cancer exampl summaryxb_a kmplotxb_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameenestg_a aliasenestg_a titleenestg figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm imatinib nilotinib cr sourc blay jy shen l kang yk et al nilotinib versu imatinib firstlin therapi patient unresect metastat gastrointestin stromal tumour enestg randomis phase trial lancet oncol usag enestg_a descript kaplanmei digit data enestg figur pmid report sampl size primari endpoint pf colorect cancer exampl summaryenestg_a kmplotenestg_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemar_a aliasmar_a titlemar figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm l placebo cr sourc goss pe ingl jn pritchard ki et al extend aromataseinhibitor adjuv therapi year n engl j med usag mar_a descript kaplanmei digit data mar figur pmid report sampl size primari endpoint df breast cancer exampl summarymar_a kmplotmar_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namegim_ aliasgim_ titlegim figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm control lhrha cr sourc lambertini boni l michelotti et al ovarian suppress triptorelin adjuv breast cancer chemotherapi longterm ovarian function pregnanc diseasefre surviv random clinic trial jama usag gim_ descript kaplanmei digit data gim figur pmid report sampl size primari endpoint incidence_chemoinduc menopaus breast cancer exampl summarygim_ kmplotgim_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namehypro_b aliashypro_b titlehypro figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm convent fraction hypofraction cr sourc incrocci l wortel rc alemayehu wg et al hypofraction versu convent fraction radiotherapi patient localis prostat cancer hypro final efficaci result randomis multicentr openlabel phase trial lancet oncol usag hypro_b descript kaplanmei digit data hypro figur b pmid report sampl size primari endpoint rf prostat cancer exampl summaryhypro_b kmplothypro_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namegim_d aliasgim_d titlegim figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm q q cr sourc del mastro l de placido bruzzi p et al fluorouracil dosedens chemotherapi adjuv treatment patient earlystag breast cancer openlabel factori randomis phase trial lancet usag gim_d descript kaplanmei digit data gim figur pmid report sampl size primari endpoint df breast cancer exampl summarygim_d kmplotgim_d keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameca_ aliasca_ titleca figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm ipilimumab placebo cr sourc beer tm kwon ed drake cg et al random doubleblind phase iii trial ipilimumab versu placebo asymptomat minim symptomat patient metastat chemotherapyna castrationresist prostat cancer j clin oncol usag ca_ descript kaplanmei digit data ca figur pmid report sampl size primari endpoint os prostat cancer exampl summaryca_ kmplotca_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameibcsg_a aliasibcsg_a titleibcsg figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm cm cm cr sourc colleoni gray kp gelber et al lowdos oral cyclophosphamid methotrex mainten hormon receptorneg earli breast cancer intern breast cancer studi group trial j clin oncol usag ibcsg_a descript kaplanmei digit data ibcsg figur pmid report sampl size primari endpoint df breast cancer exampl summaryibcsg_a kmplotibcsg_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameluxlung_a aliasluxlung_a titleluxlung figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm afatinib erlotinib cr sourc soria jc felip e cobo et al afatinib versu erlotinib secondlin treatment patient advanc squamou cell carcinoma lung luxlung openlabel randomis control phase trial lancet oncol usag luxlung_a descript kaplanmei digit data luxlung figur pmid report sampl size primari endpoint pf lung cancer exampl summaryluxlung_a kmplotluxlung_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameneoalttoa_d aliasneoalttoa_d titleneoalttoa figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm l cr sourc de azambuja e holm ap piccartgebhart et al lapatinib trastuzumab herposit earli breast cancer neoaltto surviv outcom randomis openlabel multicentr phase trial associ patholog complet respons lancet oncol usag neoalttoa_d descript kaplanmei digit data neoalttoa figur pmid report sampl size primari endpoint pcr breast cancer exampl summaryneoalttoa_d kmplotneoalttoa_d keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namertog_c aliasrtog_c titlertog figur c format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm observ rt cr sourc mccormick b winter k hudi c et al rtog prospect random trial goodrisk ductal carcinoma situ compar radiotherapi observ j clin oncol usag rtog_c descript kaplanmei digit data rtog figur c pmid report sampl size primari endpoint ilf breast cancer exampl summaryrtog_c kmplotrtog_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namer_ aliasr_ titler figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm fulv fulv_cpt cr sourc delbaldo c ychou zawadi et al postop irinotecan resect stage iiiii rectal cancer final analysi french r intergroup trial ann oncol usag r_ descript kaplanmei digit data r figur pmid report sampl size primari endpoint df colorect cancer exampl summaryr_ kmplotr_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameproclaim_b aliasproclaim_b titleproclaim figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm eto_ci pem_ci cr sourc senan brade wang lh et al proclaim random phase iii trial pemetrexedcisplatin etoposidecisplatin plu thorac radiat therapi follow consolid chemotherapi local advanc nonsquam nonsmallcel lung cancer j clin oncol usag proclaim_b descript kaplanmei digit data proclaim figur b pmid report sampl size primari endpoint os lung cancer exampl summaryproclaim_b kmplotproclaim_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namewjogl_b aliaswjogl_b titlewjogl figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm cisplatin_docetaxel nedaplatin_docetaxel cr sourc shukuya yamanaka seto et al nedaplatin plu docetaxel versu cisplatin plu docetaxel advanc relaps squamou cell carcinoma lung wjogl randomis openlabel phase trial lancet oncol usag wjogl_b descript kaplanmei digit data wjogl figur b pmid report sampl size primari endpoint os lung cancer exampl summarywjogl_b kmplotwjogl_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namertog_b aliasrtog_b titlertog figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cetuximab no_cetuximab cr sourc bradley jd paulu r komaki r et al standarddos versu highdos conform radiotherapi concurr consolid carboplatin plu paclitaxel without cetuximab patient stage iiia iiib nonsmallcel lung cancer rtog randomis twobytwo factori phase studi lancet oncol usag rtog_b descript kaplanmei digit data rtog figur b pmid report sampl size primari endpoint os lung cancer exampl summaryrtog_b kmplotrtog_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameelmpc_b aliaselmpc_b titleelmpc figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm orteronel placebo cr sourc fizazi k jone r oudard et al phase iii random doubleblind multicent trial compar orteronel tak plu prednison placebo plu prednison patient metastat castrationresist prostat cancer progress docetaxelbas therapi elmpc j clin oncol usag elmpc_b descript kaplanmei digit data elmpc figur b pmid report sampl size primari endpoint os prostat cancer exampl summaryelmpc_b kmplotelmpc_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namechronicle_a aliaschronicle_a titlechronicl figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm capecitabine_oxaliplatin follow_up_onli cr sourc glynnejon r counsel n quirk p et al chronicl result randomis phase iii trial local advanc rectal cancer neoadjuv chemoradi randomis postop adjuv capecitabin plu oxaliplatin xelox versu control ann oncol usag chronicle_a descript kaplanmei digit data chronicl figur pmid report sampl size primari endpoint df colorect cancer exampl summarychronicle_a kmplotchronicle_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameaioa_b aliasaioa_b titleaioa figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm fu_bev no_tx cr sourc hegewischbeck graeven u lerchenm√ºl ca et al mainten strategi firstlin oxaliplatin plu fluoropyrimidin plu bevacizumab patient metastat colorect cancer aio randomis noninferior openlabel phase trial lancet oncol usag aioa_b descript kaplanmei digit data aioa figur b pmid report sampl size primari endpoint time_tx_failur colorect cancer exampl summaryaioa_b kmplotaioa_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namedart_b aliasdart_b titledart figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm ltad stad cr sourc zapatero guerrero maldonado x et al highdos radiotherapi shortterm longterm androgen depriv localis prostat cancer dart gicor randomis control phase trial lancet oncol usag dart_b descript kaplanmei digit data dart figur b pmid report sampl size primari endpoint bdf prostat cancer exampl summarydart_b kmplotdart_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namejfmc_b aliasjfmc_b titlejfmc figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm control studi cr sourc sadahiro tsuchiya sasaki k et al random phase iii trial treatment durat oral uracil tegafur plu leucovorin adjuv chemotherapi patient stage iibiii colon cancer final result jfmc ann oncol usag jfmc_b descript kaplanmei digit data jfmc figur b pmid report sampl size primari endpoint df colorect cancer exampl summaryjfmc_b kmplotjfmc_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameca_a aliasca_a titleca figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm ipilimumab placebo cr sourc kwon ed drake cg scher hi et al ipilimumab versu placebo radiotherapi patient metastat castrationresist prostat cancer progress docetaxel chemotherapi ca multicentr randomis doubleblind phase trial lancet oncol usag ca_a descript kaplanmei digit data ca figur pmid report sampl size primari endpoint os prostat cancer exampl summaryca_a kmplotca_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecalgb_c aliascalgb_c titlecalgb figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm ixabepilon p cr sourc rugo hs barri wt morenoaspitia et al random phase iii trial paclitaxel per week compar nanoparticl albuminbound nabpaclitaxel per week ixabepilon bevacizumab firstlin chemotherapi local recurr metastat breast cancer calgb ncctg nh allianc j clin oncol usag calgb_c descript kaplanmei digit data calgb figur c pmid report sampl size primari endpoint pf breast cancer exampl summarycalgb_c kmplotcalgb_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameinspire_b aliasinspire_b titleinspir figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm ct necitumumab_ct cr sourc pazar l mezger j ciuleanu te et al necitumumab plu pemetrex cisplatin firstlin therapi patient stage iv nonsquam nonsmallcel lung cancer inspir openlabel randomis control phase studi lancet oncol usag inspire_b descript kaplanmei digit data inspir figur b pmid report sampl size primari endpoint os lung cancer exampl summaryinspire_b kmplotinspire_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameespatue_ aliasespatue_ titleespatu figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm arma armb cr sourc eberhardt wee p√∂ttgen c gauler tc et al phase iii studi surgeri versu definit concurr chemoradiotherapi boost patient resect stage iiian select iiib nonsmallcel lung cancer induct chemotherapi concurr chemoradiotherapi espatu j clin oncol usag espatue_ descript kaplanmei digit data espatu figur pmid report sampl size primari endpoint os lung cancer exampl summaryespatue_ kmplotespatue_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecheckmate_ aliascheckmate_ titlecheckm figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm nivolumab cr sourc brahmer j reckamp kl baa p et al nivolumab versu docetaxel advanc squamouscel nonsmallcel lung cancer n engl j med usag checkmate_ descript kaplanmei digit data checkmat figur pmid report sampl size primari endpoint os lung cancer exampl summarycheckmate_ kmplotcheckmate_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameluxlung_a aliasluxlung_a titleluxlung figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm afatinib erlotinib cr sourc soria jc felip e cobo et al afatinib versu erlotinib secondlin treatment patient advanc squamou cell carcinoma lung luxlung openlabel randomis control phase trial lancet oncol usag luxlung_a descript kaplanmei digit data luxlung figur pmid report sampl size primari endpoint pf lung cancer exampl summaryluxlung_a kmplotluxlung_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemirox_a aliasmirox_a titlemirox figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm folfox folfox_folfiri cr sourc hebbar chibaudel b andr√© et al folfox versu sequenti dosedens folfox follow folfiri patient resect metastat colorect cancer mirox pragmat approach chemotherapi time periop postop chemotherapi openlabel random phase iii trial ann oncol usag mirox_a descript kaplanmei digit data mirox figur pmid report sampl size primari endpoint dfsyr colorect cancer exampl summarymirox_a kmplotmirox_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_b aliasnct_b titlenct figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm cap eribulin cr sourc kaufman pa awada twelv c et al phase iii openlabel random studi eribulin mesyl versu capecitabin patient local advanc metastat breast cancer previous treat anthracyclin taxan j clin oncol usag nct_b descript kaplanmei digit data nct figur b pmid report sampl size primari endpoint ospf breast cancer exampl summarynct_b kmplotnct_b keyworddataset gener roxygen edit hand pleas edit document rdatademor doctypedata namekmdata_key aliaskmdata_key titlecodekmdata key format data frame observ variabl tabularll tab codenam tab uniqu data set identifi use access data set analysi cr tab codejourn tab publish journal cr tab codepubmedid tab public pubm identifi cr tab codetrialregistr tab trial registr identifi applic exampl clinicaltrialsgov identifi nct number cr tab codetitl tab public titl cr tab codeyear tab public year cr tab codeclinicaltri tab uniqu clinic trial identifi note codeclinicaltri codefigur join creat uniqu trialfigur identifi codenam cr tab codefigur tab figur identifi note codeclinicaltri codefigur join creat uniqu trialfigur identifi codenam cr tab codecanc tab studi cancer type cr tab codesubgroup tab subgroup studi cr tab codereportedsamples tab overal studi sampl size cr tab coderandomizationratio tab ratio patient random studi arm cr tab coderandomizationtyp tab treatment characterist patient random eg patient random receiv differ dose level durat time therapi therapi agent cr tab codetrialdesign tab trial design ie superior inferior cr tab codemetastat tab indic metastat nonmetastat cancer cr tab codeinterventionclass tab class drugtreat use interventiontreat arm cr tab codeoutcom tab outcom event data set eg os pf df etc cr tab codeprimarystudyresult tab primari outcom result either posit neg mix ie coprimari endpoint posit neg outcom cr tab codeunit tab time unit codeoutcom eg day week month year cr tab codehazardratio tab reportedpublish hazard ratio codeoutcom cr tab codearm tab two treatment arm data set cr tab codenumberofarm tab number treatment arm entir studi note data set packag two arm cr tab codeqsatrisk tab qualiti score atrisk tabl cr tab codeqstotalev tab qualiti score total event cr tab codeqshazardratio tab qualiti score hazard ratio cr tab codeqsmedian tab qualiti score median timetoev cr tab codequalityscor tab aggreg qualiti score figur four metric hazard ratio total event median timetoev number atrisk compar publish recapitul data cr tab codequalitymax tab maximum qualiti score possibl figur qualiti metric score worst best maximum score possibl figur depend number metric report public cr tab codequalityperc tab qualiti score percentag figur worst best codequalityscor qualitymax cr usag kmdata_key descript descript data set avail codekmdata packag seealso codelinkkmdata_demo codelinkselect_kmdata codelinksummarykmdata keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namehypro_a aliashypro_a titlehypro figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab rf event indic code event code event cr tab codearm tab treatment arm convent fraction hypofraction cr sourc incrocci l wortel rc alemayehu wg et al hypofraction versu convent fraction radiotherapi patient localis prostat cancer hypro final efficaci result randomis multicentr openlabel phase trial lancet oncol usag hypro_a descript kaplanmei digit data hypro figur pmid report sampl size primari endpoint rf prostat cancer exampl summaryhypro_a kmplothypro_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namesquire_a aliassquire_a titlesquir figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm gem_ci necitumumab_gem_ci cr sourc thatcher n hirsch fr luft av et al necitumumab plu gemcitabin cisplatin versu gemcitabin cisplatin alon firstlin therapi patient stage iv squamou nonsmallcel lung cancer squir openlabel randomis control phase trial lancet oncol usag squire_a descript kaplanmei digit data squir figur pmid report sampl size primari endpoint os lung cancer exampl summarysquire_a kmplotsquire_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameraise_a aliasraise_a titlerais figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm placebo_folfiri ramucirumab_folfiri cr sourc tabernero j yoshino cohn al et al ramucirumab versu placebo combin secondlin folfiri patient metastat colorect carcinoma progress firstlin therapi bevacizumab oxaliplatin fluoropyrimidin rais randomis doubleblind multicentr phase studi lancet oncol usag raise_a descript kaplanmei digit data rais figur pmid report sampl size primari endpoint os colorect cancer exampl summaryraise_a kmplotraise_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namechhipa_a aliaschhipa_a titlechhipa figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab rf event indic code event code event cr tab codearm tab treatment arm gy gy cr sourc dearnaley syndiku mossop h et al convent versu hypofraction highdos intensitymodul radiotherapi prostat cancer year outcom randomis noninferior phase chhip trial lancet oncol usag chhipa_a descript kaplanmei digit data chhipa figur pmid report sampl size primari endpoint brf prostat cancer exampl summarychhipa_a kmplotchhipa_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namerevel_ aliasrevel_ titlerevel figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm placebo_docetaxel ramucirumab_docetaxel cr sourc garon eb ciuleanu te arrieta et al ramucirumab plu docetaxel versu placebo plu docetaxel secondlin treatment stage iv nonsmallcel lung cancer diseas progress platinumbas therapi revel multicentr doubleblind randomis phase trial lancet usag revel_ descript kaplanmei digit data revel figur pmid report sampl size primari endpoint os lung cancer exampl summaryrevel_ kmplotrevel_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameea_a aliasea_a titleea figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm p p cr sourc sparano ja zhao f martino et al longterm followup e phase iii trial evalu role taxan schedul oper breast cancer j clin oncol usag ea_a descript kaplanmei digit data ea figur pmid report sampl size primari endpoint df breast cancer exampl summaryea_a kmplotea_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameespatue_ aliasespatue_ titleespatu figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm arma armb cr sourc eberhardt wee p√∂ttgen c gauler tc et al phase iii studi surgeri versu definit concurr chemoradiotherapi boost patient resect stage iiian select iiib nonsmallcel lung cancer induct chemotherapi concurr chemoradiotherapi espatu j clin oncol usag espatue_ descript kaplanmei digit data espatu figur pmid report sampl size primari endpoint os lung cancer exampl summaryespatue_ kmplotespatue_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namewsgara_ aliaswsgara_ titlewsgara figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab ef event indic code event code event cr tab codearm tab treatment arm da_neg da_posit cr sourc nitz u gluz zuna et al final result prospect phase iii wsgara trial impact adjuv darbepoetin alfa eventfre surviv earli breast cancer ann oncol usag wsgara_ descript kaplanmei digit data wsgara figur pmid report sampl size primari endpoint ef breast cancer exampl summarywsgara_ kmplotwsgara_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameno_c aliasno_c titleno figur c format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm fu_fa xelox cr sourc schmoll hj tabernero j maroun j et al capecitabin plu oxaliplatin compar fluorouracilfolin acid adjuv therapi stage iii colon cancer final result random control phase iii trial j clin oncol usag no_c descript kaplanmei digit data figur c pmid report sampl size primari endpoint df colorect cancer exampl summaryno_c kmplotno_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameffcd_sc aliasffcd_sc titleffcd figur sc format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm classic simplifi cr sourc aparicio lavauden phelip jm et al random phase iii trial elderli patient compar lvfu without irinotecan firstlin treatment metastat colorect cancer ffcd ann oncol usag ffcd_sc descript kaplanmei digit data ffcd figur sc pmid report sampl size primari endpoint pf colorect cancer exampl summaryffcd_sc kmplotffcd_sc keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namegetug_ aliasgetug_ titlegetug figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm rt rt_goserelin cr sourc carri c hasbini de laroch g et al salvag radiotherapi without shortterm hormon therapi rise prostatespecif antigen concentr radic prostatectomi getugafu randomis multicentr openlabel phase trial lancet oncol usag getug_ descript kaplanmei digit data getug figur pmid report sampl size primari endpoint pf prostat cancer exampl summarygetug_ kmplotgetug_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameaiob_b aliasaiob_b titleaiob figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm fu_bev bev cr sourc hegewischbeck graeven u lerchenm√ºl ca et al mainten strategi firstlin oxaliplatin plu fluoropyrimidin plu bevacizumab patient metastat colorect cancer aio randomis noninferior openlabel phase trial lancet oncol usag aiob_b descript kaplanmei digit data aiob figur b pmid report sampl size primari endpoint time_tx_failur colorect cancer exampl summaryaiob_b kmplotaiob_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameradiant_a aliasradiant_a titleradi figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm everolimu placebo cr sourc yao jc fazio n singh et al everolimu treatment advanc nonfunct neuroendocrin tumour lung gastrointestin tract radiant randomis placebocontrol phase studi lancet usag radiant_a descript kaplanmei digit data radiant figur pmid report sampl size primari endpoint pf lungcolorect cancer exampl summaryradiant_a kmplotradiant_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameradiant_a aliasradiant_a titleradi figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm erlotinib placebo cr sourc kelli k altorki nk eberhardt wee et al adjuv erlotinib versu placebo patient stage ibiiia nonsmallcel lung cancer radiant random doubleblind phase iii trial j clin oncol usag radiant_a descript kaplanmei digit data radiant figur pmid report sampl size primari endpoint df lung cancer exampl summaryradiant_a kmplotradiant_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namesakk_ aliassakk_ titlesakk figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm bev no_bev cr sourc koeberl bettich dc von moo r et al bevacizumab continu versu continu firstlin chemotherapi plu bevacizumab patient metastat colorect cancer random phase iii noninferior trial sakk ann oncol usag sakk_ descript kaplanmei digit data sakk figur pmid report sampl size primari endpoint ttp colorect cancer exampl summarysakk_ kmplotsakk_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameelmpc_a aliaselmpc_a titleelmpc figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm orteronel placebo cr sourc saad f fizazi k jinga v et al orteronel plu prednison patient chemotherapyna metastat castrationresist prostat cancer elmpc doubleblind multicentr phase randomis placebocontrol trial lancet oncol usag elmpc_a descript kaplanmei digit data elmpc figur pmid report sampl size primari endpoint rpfso prostat cancer exampl summaryelmpc_a kmplotelmpc_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameconcur_a aliasconcur_a titleconcur figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm placebo regorafenib cr sourc li j qin xu r et al regorafenib plu best support care versu placebo plu best support care asian patient previous treat metastat colorect cancer concur randomis doubleblind placebocontrol phase trial lancet oncol usag concur_a descript kaplanmei digit data concur figur pmid report sampl size primari endpoint os colorect cancer exampl summaryconcur_a kmplotconcur_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namewsgago_a aliaswsgago_a titlewsgago figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab ef event indic code event code event cr tab codearm tab treatment arm control ed_doc cr sourc nitz u gluz huober j et al final analysi prospect wsgago ecdoc versu fec phase iii trial intermediaterisk pn earli breast cancer efficaci predict valu ki express ann oncol usag wsgago_a descript kaplanmei digit data wsgago figur pmid report sampl size primari endpoint ef breast cancer exampl summarywsgago_a kmplotwsgago_a keyworddataset gener roxygen edit hand pleas edit document rkmdatapackag doctypepackag namekmdatapackag aliaskmdatapackag aliaskmdata titlekmdata descript reconstruct kaplanmei data public gather hrefhttpspubmedncbinlmnihgovpubm detail data set gather pubm limit phase random trial complet januari st decemb st publish jama oncolog new england journal medicin lancet lancet oncolog journal clinic oncolog annal oncolog journal american medic associ journal nation cancer institut final list includ figur public data span four cancer colorect lung prostat breast data set featur time event indic well treatment arm two arm per data set addit inform studi includ attribut data object key data codekmdata_key key includ public identifi journal titl outcom sampl size etc packag also includ util gener individu patient data ipd digit surviv curv data use method describ guyot see codelinkipd exampl data set includ datapackag kmdata basic usag summaryattention_a kmplotattention_b list data set estim pf select_kmdataoutcom pf list studi breast cancer fewer patient l select_kmdatacanc breast reportedsamples return data parmfrow nmfrowlengthl sapplyl kmplot seealso codelinkkmdata_key list data set avail addit inform includ data sourc outcom diseas type result qualiti recapitul data set codelinksummarykmdatasummari method summar data set codelinkkmplot plot kaplanmei curv data set codelinkselect_kmdata select studi base characterist list codelinkkmdata_key gener roxygen edit hand pleas edit document rdatar doctypedata namecalgb_b aliascalgb_b titlecalgb figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm l l_b cr sourc dickler mn barri wt cirrincion ct et al phase iii trial evalu letrozol firstlin endocrin therapi without bevacizumab treatment postmenopaus women hormon receptorposit advancedstag breast cancer calgb allianc j clin oncol usag calgb_b descript kaplanmei digit data calgb figur b pmid report sampl size primari endpoint pf breast cancer exampl summarycalgb_b kmplotcalgb_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameattention_a aliasattention_a titleattent figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm placebo tivantinib cr sourc yoshioka h azuma k yamamoto n et al random doubleblind placebocontrol phase iii trial erlotinib without cmet inhibitor tivantinib arq asian patient previous treat stage iiibiv nonsquam nonsmallcel lung cancer harbor wildtyp epiderm growth factor receptor attent studi ann oncol usag attention_a descript kaplanmei digit data attent figur pmid report sampl size primari endpoint os lung cancer exampl summaryattention_a kmplotattention_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namealttob_b aliasalttob_b titlealttob figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm t_then_l cr sourc piccartgebhart holm e baselga j et al adjuv lapatinib trastuzumab earli human epiderm growth factor receptor posit breast cancer result random phase iii adjuv lapatinib andor trastuzumab treatment optim trial j clin oncol usag alttob_b descript kaplanmei digit data alttob figur b pmid report sampl size primari endpoint df breast cancer exampl summaryalttob_b kmplotalttob_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namertog_ aliasrtog_ titlertog figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm gy gy cr sourc lee wr dignam jj amin mb et al random phase iii noninferior studi compar two radiotherapi fraction schedul patient lowrisk prostat cancer j clin oncol usag rtog_ descript kaplanmei digit data rtog figur pmid report sampl size primari endpoint df prostat cancer exampl summaryrtog_ kmplotrtog_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namethresa_a aliasthresa_a titlethresa figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm physicians_choic trastuzumab_emtansin cr sourc krop ie kim sb gonz√°lezmart√≠n et al trastuzumab emtansin versu treatment physician choic pretreat herposit advanc breast cancer thresa randomis openlabel phase trial lancet oncol usag thresa_a descript kaplanmei digit data thresa figur pmid report sampl size primari endpoint pfso breast cancer exampl summarythresa_a kmplotthresa_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameno_a aliasno_a titleno figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm fu_fa xelox cr sourc schmoll hj tabernero j maroun j et al capecitabin plu oxaliplatin compar fluorouracilfolin acid adjuv therapi stage iii colon cancer final result random control phase iii trial j clin oncol usag no_a descript kaplanmei digit data figur pmid report sampl size primari endpoint df colorect cancer exampl summaryno_a kmplotno_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameoptimox_a aliasoptimox_a titleoptimox figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm bev bev_erlotinib cr sourc tournigand c chibaudel b samson b et al bevacizumab without erlotinib mainten therapi patient metastat colorect cancer gercor dream optimox randomis openlabel phase trial lancet oncol usag optimox_a descript kaplanmei digit data optimox figur pmid report sampl size primari endpoint pf colorect cancer exampl summaryoptimox_a kmplotoptimox_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametrapeze_b aliastrapeze_b titletrapez figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm no_sr sr cr sourc jame nd pirri sj pope et al clinic outcom surviv follow treatment metastat castraterefractori prostat cancer docetaxel alon strontium zoledron acid trapez random clinic trial jama oncol usag trapeze_b descript kaplanmei digit data trapez figur b pmid report sampl size primari endpoint cpfscosteffect prostat cancer exampl summarytrapeze_b kmplottrapeze_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameprofile_b aliasprofile_b titleprofil figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm chemo crizotinib cr sourc solomon bj mok kim dw et al firstlin crizotinib versu chemotherapi alkposit lung cancer n engl j med usag profile_b descript kaplanmei digit data profil figur b pmid report sampl size primari endpoint pf lung cancer exampl summaryprofile_b kmplotprofile_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namensabpb_a aliasnsabpb_a titlensabpb figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm bev no_bev cr sourc bear hd tang g rastogi p et al neoadjuv plu adjuv bevacizumab earli breast cancer nsabp b nrg oncolog secondari outcom phase randomis control trial lancet oncol usag nsabpb_a descript kaplanmei digit data nsabpb figur pmid report sampl size primari endpoint pcr breast cancer exampl summarynsabpb_a kmplotnsabpb_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecleopatra_a aliascleopatra_a titlecleopatra figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm control pertuzumab cr sourc swain sm baselga j kim sb et al pertuzumab trastuzumab docetaxel herposit metastat breast cancer n engl j med usag cleopatra_a descript kaplanmei digit data cleopatra figur pmid report sampl size primari endpoint pf breast cancer exampl summarycleopatra_a kmplotcleopatra_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebeyond_a aliasbeyond_a titlebeyond figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm bev_cp placebo_cp cr sourc zhou c wu yl chen g et al beyond random doubleblind placebocontrol multicent phase iii studi firstlin carboplatinpaclitaxel plu bevacizumab placebo chines patient advanc recurr nonsquam nonsmallcel lung cancer j clin oncol usag beyond_a descript kaplanmei digit data beyond figur pmid report sampl size primari endpoint pf prostat cancer exampl summarybeyond_a kmplotbeyond_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecbcsg_b aliascbcsg_b titlecbcsg figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cis_gemcitabin paclitaxel_gemcitabin cr sourc hu xc zhang j xu bh et al cisplatin plu gemcitabin versu paclitaxel plu gemcitabin firstlin therapi metastat tripleneg breast cancer cbcsg randomis openlabel multicentr phase trial lancet oncol usag cbcsg_b descript kaplanmei digit data cbcsg figur b pmid report sampl size primari endpoint pf breast cancer exampl summarycbcsg_b kmplotcbcsg_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namedelta_a aliasdelta_a titledelta figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm erlotinib cr sourc kawaguchi ando asami k et al random phase iii trial erlotinib versu docetaxel second thirdlin therapi patient advanc nonsmallcel lung cancer docetaxel erlotinib lung cancer trial delta j clin oncol usag delta_a descript kaplanmei digit data delta figur pmid report sampl size primari endpoint pf lung cancer exampl summarydelta_a kmplotdelta_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namethresa_ aliasthresa_ titlethresa figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm physicians_choic trastuzumab_emtansin cr sourc krop ie kim sb gonz√°lezmart√≠n et al trastuzumab emtansin versu treatment physician choic pretreat herposit advanc breast cancer thresa randomis openlabel phase trial lancet oncol usag thresa_ descript kaplanmei digit data thresa figur pmid report sampl size primari endpoint pfso breast cancer exampl summarythresa_ kmplotthresa_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namertog_a aliasrtog_a titlertog figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm gy gy cr sourc bradley jd paulu r komaki r et al standarddos versu highdos conform radiotherapi concurr consolid carboplatin plu paclitaxel without cetuximab patient stage iiia iiib nonsmallcel lung cancer rtog randomis twobytwo factori phase studi lancet oncol usag rtog_a descript kaplanmei digit data rtog figur pmid report sampl size primari endpoint os lung cancer exampl summaryrtog_a kmplotrtog_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namewjogl_a aliaswjogl_a titlewjogl figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm erlotinib gefitinib cr sourc urata katakami n morita et al random phase iii studi compar gefitinib erlotinib patient previous treat advanc lung adenocarcinoma wjog l j clin oncol usag wjogl_a descript kaplanmei digit data wjogl figur pmid report sampl size primari endpoint pf lung cancer exampl summarywjogl_a kmplotwjogl_a keyworddataset gener roxygen edit hand pleas edit document rutilsr namesummarykmdata aliassummarykmdata titlesummar codekmdata usag methodsummarykmdataobject messag true argument itemobjectan object class codekmdata itemmessagelog codetru default descript studi print summari itemignor descript print summari codekmdata object exampl summaryattention_a gener roxygen edit hand pleas edit document rdatar doctypedata nameitaca_b aliasitaca_b titleitaca figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm ct ct_b cr sourc passardi nanni tassinari et al effect bevacizumab ad standard chemotherapi metastat colorect cancer final result firstlin treatment itaca random clinic trial ann oncol usag itaca_b descript kaplanmei digit data itaca figur b pmid report sampl size primari endpoint pf colorect cancer exampl summaryitaca_b kmplotitaca_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenctb_b aliasnctb_b titlenctb figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm armb armc cr sourc sclafani f kim ty cunningham et al random phase iiiii studi dalotuzumab combin cetuximab irinotecan chemorefractori kra wildtyp metastat colorect cancer j natl cancer inst djv usag nctb_b descript kaplanmei digit data nctb figur b pmid report sampl size primari endpoint pfso colorect cancer exampl summarynctb_b kmplotnctb_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namegecestroapbi_ aliasgecestroapbi_ titlegecestroapbi figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm apbi wbi cr sourc strnad v ott oj hildebrandt g et al year result acceler partial breast irradi use sole interstiti multicathet brachytherapi versu wholebreast irradi boost breastconserv surgeri lowrisk invas insitu carcinoma femal breast randomis phase noninferior trial lancet usag gecestroapbi_ descript kaplanmei digit data gecestroapbi figur pmid report sampl size primari endpoint lr breast cancer exampl summarygecestroapbi_ kmplotgecestroapbi_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namentr_ aliasntr_ titlentr figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm control thorac rt cr sourc slotman bj van tinteren h praag jo et al use thorac radiotherapi extens stage smallcel lung cancer phase randomis control trial lancet usag ntr_ descript kaplanmei digit data ntr figur pmid report sampl size primari endpoint osyr lung cancer exampl summaryntr_ kmplotntr_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecbcsg_a aliascbcsg_a titlecbcsg figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm cis_gemcitabin paclitaxel_gemcitabin cr sourc hu xc zhang j xu bh et al cisplatin plu gemcitabin versu paclitaxel plu gemcitabin firstlin therapi metastat tripleneg breast cancer cbcsg randomis openlabel multicentr phase trial lancet oncol usag cbcsg_a descript kaplanmei digit data cbcsg figur pmid report sampl size primari endpoint pf breast cancer exampl summarycbcsg_a kmplotcbcsg_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namevantage_ aliasvantage_ titlevantag figur format data frame observ variabl tabularll tab codetim tab event time week cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm placebo vorinostat cr sourc krug lm kindler hl calvert h et al vorinostat patient advanc malign pleural mesothelioma progress previou chemotherapi vantag phase doubleblind randomis placebocontrol trial lancet oncol usag vantage_ descript kaplanmei digit data vantag figur pmid report sampl size primari endpoint ossafeti lung cancer exampl summaryvantage_ kmplotvantage_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namealttoa_a aliasalttoa_a titlealttoa figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm l_t cr sourc piccartgebhart holm e baselga j et al adjuv lapatinib trastuzumab earli human epiderm growth factor receptor posit breast cancer result random phase iii adjuv lapatinib andor trastuzumab treatment optim trial j clin oncol usag alttoa_a descript kaplanmei digit data alttoa figur pmid report sampl size primari endpoint df breast cancer exampl summaryalttoa_a kmplotalttoa_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenoah_a aliasnoah_a titlenoah figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab ef event indic code event code event cr tab codearm tab treatment arm chemo chemotherapy_trastuzumab cr sourc gianni l eiermann w semiglazov v et al neoadjuv adjuv trastuzumab patient herposit local advanc breast cancer noah followup randomis control superior trial parallel herneg cohort lancet oncol usag noah_a descript kaplanmei digit data noah figur pmid report sampl size primari endpoint ef breast cancer exampl summarynoah_a kmplotnoah_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_a aliasnct_a titlenct figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm placebo tasq cr sourc sternberg c armstrong pili r et al random doubleblind placebocontrol phase iii studi tasquinimod men metastat castrationresist prostat cancer j clin oncol usag nct_a descript kaplanmei digit data nct figur pmid report sampl size primari endpoint rpf prostat cancer exampl summarynct_a kmplotnct_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecleopatra_a aliascleopatra_a titlecleopatra figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm control pertuzumab cr sourc swain sm baselga j kim sb et al pertuzumab trastuzumab docetaxel herposit metastat breast cancer n engl j med usag cleopatra_a descript kaplanmei digit data cleopatra figur pmid report sampl size primari endpoint pf breast cancer exampl summarycleopatra_a kmplotcleopatra_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namerecourse_a aliasrecourse_a titlerecours figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm placebo ta cr sourc mayer rj van cutsem e falcon et al random trial ta refractori metastat colorect cancer n engl j med usag recourse_a descript kaplanmei digit data recours figur pmid report sampl size primari endpoint os breast cancer exampl summaryrecourse_a kmplotrecourse_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameomega_b aliasomega_b titleomega figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cap peg_doxorubicin cr sourc smorenburg ch de groot sm van leeuwenstok ae et al random phase iii studi compar pegyl liposom doxorubicin capecitabin firstlin chemotherapi elderli patient metastat breast cancer result omega studi dutch breast cancer research group boog ann oncol usag omega_b descript kaplanmei digit data omega figur b pmid report sampl size primari endpoint pf breast cancer exampl summaryomega_b kmplotomega_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecheckmate_b aliascheckmate_b titlecheckm figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm nivolumab cr sourc brahmer j reckamp kl baa p et al nivolumab versu docetaxel advanc squamouscel nonsmallcel lung cancer n engl j med usag checkmate_b descript kaplanmei digit data checkmat figur b pmid report sampl size primari endpoint os lung cancer exampl summarycheckmate_b kmplotcheckmate_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameelmpc_a aliaselmpc_a titleelmpc figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm orteronel placebo cr sourc fizazi k jone r oudard et al phase iii random doubleblind multicent trial compar orteronel tak plu prednison placebo plu prednison patient metastat castrationresist prostat cancer progress docetaxelbas therapi elmpc j clin oncol usag elmpc_a descript kaplanmei digit data elmpc figur pmid report sampl size primari endpoint os prostat cancer exampl summaryelmpc_a kmplotelmpc_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecalgb_a aliascalgb_a titlecalgb figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm l l_b cr sourc dickler mn barri wt cirrincion ct et al phase iii trial evalu letrozol firstlin endocrin therapi without bevacizumab treatment postmenopaus women hormon receptorposit advancedstag breast cancer calgb allianc j clin oncol usag calgb_a descript kaplanmei digit data calgb figur pmid report sampl size primari endpoint pf breast cancer exampl summarycalgb_a kmplotcalgb_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameeortc_ aliaseortc_ titleeortc figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm boost boost cr sourc bartelink h maingon p poortman p et al wholebreast irradi without boost patient treat breastconserv surgeri earli breast cancer year followup randomis phase trial lancet oncol usag eortc_ descript kaplanmei digit data eortc figur pmid report sampl size primari endpoint os breast cancer exampl summaryeortc_ kmploteortc_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namejcog_a aliasjcog_a titlejcog figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm combination_chemotherapi topotecan cr sourc goto k ohe shibata et al combin chemotherapi cisplatin etoposid irinotecan versu topotecan alon secondlin treatment patient sensit relaps smallcel lung cancer jcog multicentr openlabel randomis phase trial lancet oncol usag jcog_a descript kaplanmei digit data jcog figur pmid report sampl size primari endpoint os lung cancer exampl summaryjcog_a kmplotjcog_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namecerebel_a aliascerebel_a titlecerebel figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm lapatinib_cap trastuzumab_cap cr sourc pivot x manikha ≈ºurawski b et al cerebel egf phase iii random openlabel studi lapatinib plu capecitabin versu trastuzumab plu capecitabin patient human epiderm growth factor receptor posit metastat breast cancer j clin oncol usag cerebel_a descript kaplanmei digit data cerebel figur pmid report sampl size primari endpoint incidence_cnsmet breast cancer exampl summarycerebel_a kmplotcerebel_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namerecourse_a aliasrecourse_a titlerecours figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm placebo ta cr sourc mayer rj van cutsem e falcon et al random trial ta refractori metastat colorect cancer n engl j med usag recourse_a descript kaplanmei digit data recours figur pmid report sampl size primari endpoint os breast cancer exampl summaryrecourse_a kmplotrecourse_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameselectbc_b aliasselectbc_b titleselectbc figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab ttf event indic code event code event cr tab codearm tab treatment arm taxan cr sourc takashima mukai h hara f et al taxan versu firstlin chemotherapi metastat breast cancer select bc openlabel noninferior randomis phase trial lancet oncol usag selectbc_b descript kaplanmei digit data selectbc figur b pmid report sampl size primari endpoint os breast cancer exampl summaryselectbc_b kmplotselectbc_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namepaloma_a aliaspaloma_a titlepaloma figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm fulvestrant_palbociclib fulvestrant_placebo cr sourc cristofanilli turner nc bondarenko et al fulvestr plu palbociclib versu fulvestr plu placebo treatment hormonereceptorposit herneg metastat breast cancer progress previou endocrin therapi paloma final analysi multicentr doubleblind phase randomis control trial lancet oncol usag paloma_a descript kaplanmei digit data paloma figur pmid report sampl size primari endpoint pf breast cancer exampl summarypaloma_a kmplotpaloma_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametrog_ aliastrog_ titletrog figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm delayed_adt immediate_adt cr sourc duchesn gm woo hh bassett jk et al time androgendepriv therapi patient prostat cancer rise psa trog vcog pr toad randomis multicentr nonblind phase trial lancet oncol usag trog_ descript kaplanmei digit data trog figur pmid report sampl size primari endpoint os prostat cancer exampl summarytrog_ kmplottrog_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenctb_a aliasnctb_a titlenctb figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm armb armc cr sourc sclafani f kim ty cunningham et al random phase iiiii studi dalotuzumab combin cetuximab irinotecan chemorefractori kra wildtyp metastat colorect cancer j natl cancer inst djv usag nctb_a descript kaplanmei digit data nctb figur pmid report sampl size primari endpoint pfso colorect cancer exampl summarynctb_a kmplotnctb_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemainsail_b aliasmainsail_b titlemainsail figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm lenolidomid placebo cr sourc petrylak dp vogelzang nj budnik n et al docetaxel prednison without lenalidomid chemotherapyna patient metastat castrationresist prostat cancer mainsail randomis doubleblind placebocontrol phase trial lancet oncol usag mainsail_b descript kaplanmei digit data mainsail figur b pmid report sampl size primari endpoint os prostat cancer exampl summarymainsail_b kmplotmainsail_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namepetacc_a aliaspetacc_a titlepetacc figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm folfox folfox_cetuximab cr sourc taieb j tabernero j mini e et al oxaliplatin fluorouracil leucovorin without cetuximab patient resect stage iii colon cancer petacc openlabel randomis phase trial lancet oncol usag petacc_a descript kaplanmei digit data petacc figur pmid report sampl size primari endpoint df colorect cancer exampl summarypetacc_a kmplotpetacc_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namebeacon_b aliasbeacon_b titlebeacon figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm control etirinotecan_pegol cr sourc perez ea awada oshaughnessi j et al etirinotecan pegol nktr versu treatment physician choic women advanc breast cancer previous treat anthracyclin taxan capecitabin beacon randomis openlabel multicentr phase trial lancet oncol usag beacon_b descript kaplanmei digit data beacon figur b pmid report sampl size primari endpoint os breast cancer exampl summarybeacon_b kmplotbeacon_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameaspecct_a aliasaspecct_a titleaspecct figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm cetuximab panitumumab cr sourc price tj peeter kim tw et al panitumumab versu cetuximab patient chemotherapyrefractori wildtyp kra exon metastat colorect cancer aspecct randomis multicentr openlabel noninferior phase studi lancet oncol usag aspecct_a descript kaplanmei digit data aspecct figur pmid report sampl size primari endpoint os colorect cancer exampl summaryaspecct_a kmplotaspecct_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namesmx_ aliassmx_ titlesmx figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm sr upfront_chemotherapi cr sourc lim sh lee jy lee et al random phase iii trial stereotact radiosurgeri sr versu observ patient asymptomat cerebr oligometastas nonsmallcel lung cancer ann oncol usag smx_ descript kaplanmei digit data smx figur pmid report sampl size primari endpoint os lung cancer exampl summarysmx_ kmplotsmx_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenitro_b aliasnitro_b titlenitro figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm chemo nitro_chemo cr sourc davidson veillard tognela et al phase iii random trial ad topic nitroglycerin firstlin chemotherapi advanc nonsmallcel lung cancer australasian lung cancer trial group nitro trial ann oncol usag nitro_b descript kaplanmei digit data nitro figur b pmid report sampl size primari endpoint pf lung cancer exampl summarynitro_b kmplotnitro_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemindact_ aliasmindact_ titlemindact figur e format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm chemo no_chemotherapi cr sourc cardoso f vant veer lj bogaert j et al gene signatur aid treatment decis earlystag breast cancer n engl j med usag mindact_ descript kaplanmei digit data mindact figur e pmid report sampl size primari endpoint dmf breast cancer exampl summarymindact_ kmplotmindact_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namejfmc_a aliasjfmc_a titlejfmc figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm control studi cr sourc sadahiro tsuchiya sasaki k et al random phase iii trial treatment durat oral uracil tegafur plu leucovorin adjuv chemotherapi patient stage iibiii colon cancer final result jfmc ann oncol usag jfmc_a descript kaplanmei digit data jfmc figur pmid report sampl size primari endpoint df colorect cancer exampl summaryjfmc_a kmplotjfmc_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namepegase_a aliaspegase_a titlepegas figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm arma armb cr sourc gon√ßalv pierga jy ferrero jm et al unicancerpegas studi random phase iii trial evalu postop docetaxelfu regimen neoadjuv doseintens chemotherapi treatment inflammatori breast cancer ann oncol usag pegase_a descript kaplanmei digit data pegas figur pmid report sampl size primari endpoint df breast cancer exampl summarypegase_a kmplotpegase_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemagrit_c aliasmagrit_c titlemagrit figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm mage_a placebo cr sourc vansteenkist jf cho bc vanakesa et al efficaci magea cancer immunotherapeut adjuv therapi patient resect mageaposit nonsmallcel lung cancer magrit randomis doubleblind placebocontrol phase trial lancet oncol usag magrit_c descript kaplanmei digit data magrit figur c pmid report sampl size primari endpoint df primari diff pop lung cancer exampl summarymagrit_c kmplotmagrit_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namelea_c aliaslea_c titlelea figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm et et_b cr sourc mart√≠n loibl von minckwitz g et al phase iii trial evalu addit bevacizumab endocrin therapi firstlin treatment advanc breast cancer letrozolefulvestr avastin lea studi j clin oncol usag lea_c descript kaplanmei digit data lea figur c pmid report sampl size primari endpoint pf breast cancer exampl summarylea_c kmplotlea_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameercc_a aliasercc_a titleercc figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cisplatin p cr sourc lee sm falzon blackhal f et al random prospect biomark trial ercc compar platinum nonplatinum therapi advanc nonsmallcel lung cancer ercc trial et j clin oncol usag ercc_a descript kaplanmei digit data ercc figur pmid report sampl size primari endpoint os lung cancer exampl summaryercc_a kmplotercc_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameffcd_sd aliasffcd_sd titleffcd figur sd format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm classic simplifi cr sourc aparicio lavauden phelip jm et al random phase iii trial elderli patient compar lvfu without irinotecan firstlin treatment metastat colorect cancer ffcd ann oncol usag ffcd_sd descript kaplanmei digit data ffcd figur sd pmid report sampl size primari endpoint pf colorect cancer exampl summaryffcd_sd kmplotffcd_sd keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameazure_a aliasazure_a titleazur figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm control zoledronic_acid cr sourc coleman r cameron dodwel et al adjuv zoledron acid patient earli breast cancer final efficaci analysi azur big randomis openlabel phase trial lancet oncol usag azure_a descript kaplanmei digit data azur figur pmid report sampl size primari endpoint df breast cancer exampl summaryazure_a kmplotazure_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namexb_b aliasxb_b titleb figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm control pci cr sourc li n zeng zf wang sy et al random phase iii trial prophylact cranial irradi versu observ patient fulli resect stage iiian nonsmallcel lung cancer high risk cerebr metastas adjuv chemotherapi ann oncol usag xb_b descript kaplanmei digit data b figur b pmid report sampl size primari endpoint df lung cancer exampl summaryxb_b kmplotxb_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namex_a aliasx_a titl figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm folfiri panitumumab_folfiri cr sourc peeter price tj cervant et al final result random phase studi folfiri panitumumab secondlin treatment metastat colorect cancer ann oncol usag x_a descript kaplanmei digit data figur pmid report sampl size primari endpoint pfso colorect cancer exampl summaryx_a kmplotx_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameact_b aliasact_b titleact figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm mut_b mut_c cr sourc hagman h fr√∂din je berglund √• et al random studi krasguid mainten therapi bevacizumab erlotinib metronom capecitabin firstlin induct treatment metastat colorect cancer nordic act trial ann oncol usag act_b descript kaplanmei digit data act figur b pmid report sampl size primari endpoint pfsmo colorect cancer exampl summaryact_b kmplotact_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameluxlung_b aliasluxlung_b titleluxlung figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm afatinib gemicitabinecisplatin cr sourc yang jch wu yl schuler et al afatinib versu cisplatinbas chemotherapi egfr mutationposit lung adenocarcinoma luxlung luxlung analysi overal surviv data two randomis phase trial lancet oncol usag luxlung_b descript kaplanmei digit data luxlung figur b pmid report sampl size primari endpoint pf lung cancer exampl summaryluxlung_b kmplotluxlung_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namepegase_b aliaspegase_b titlepegas figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm arma armb cr sourc gon√ßalv pierga jy ferrero jm et al unicancerpegas studi random phase iii trial evalu postop docetaxelfu regimen neoadjuv doseintens chemotherapi treatment inflammatori breast cancer ann oncol usag pegase_b descript kaplanmei digit data pegas figur b pmid report sampl size primari endpoint df breast cancer exampl summarypegase_b kmplotpegase_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemaps_a aliasmaps_a titlemap figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm pc pcb cr sourc zalcman g mazier j margeri j et al bevacizumab newli diagnos pleural mesothelioma mesothelioma avastin cisplatin pemetrex studi map randomis control openlabel phase trial lancet usag maps_a descript kaplanmei digit data map figur pmid report sampl size primari endpoint os lung cancer exampl summarymaps_a kmplotmaps_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametextsoft_a aliastextsoft_a titletextsoft figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm exemestane_o tamoxifen_o cr sourc pagani regan mm walley ba et al adjuv exemestan ovarian suppress premenopaus breast cancer n engl j med usag textsoft_a descript kaplanmei digit data textsoft figur pmid report sampl size primari endpoint df breast cancer exampl summarytextsoft_a kmplottextsoft_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameprevail_a aliasprevail_a titleprevail figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab rpf event indic code event code event cr tab codearm tab treatment arm enzalutamid placebo cr sourc beer tm armstrong aj rathkopf de et al enzalutamid metastat prostat cancer chemotherapi n engl j med usag prevail_a descript kaplanmei digit data prevail figur pmid report sampl size primari endpoint pfso prostat cancer exampl summaryprevail_a kmplotprevail_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namensabpr_b aliasnsabpr_b titlensabpr figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm no_oxali oxali cr sourc allegra cj yother g oconnel mj et al neoadjuv fu capecitabin plu radiat without oxaliplatin rectal cancer patient phase iii random clinic trial j natl cancer inst doijncidjv usag nsabpr_b descript kaplanmei digit data nsabpr figur b pmid report sampl size primari endpoint localregion tumor control colorect cancer exampl summarynsabpr_b kmplotnsabpr_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemonaleesa_ aliasmonaleesa_ titlemonaleesa figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm placebo ribociclib_letrozol cr sourc hortobagyi gn stemmer sm burri ha et al ribociclib firstlin therapi hrposit advanc breast cancer n engl j med usag monaleesa_ descript kaplanmei digit data monaleesa figur pmid report sampl size primari endpoint pf breast cancer exampl summarymonaleesa_ kmplotmonaleesa_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametcog_a aliastcog_a titletcog figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm docetaxel_ci s_ci cr sourc kubota k sakai h katakami n et al random phase iii trial oral plu cisplatin versu docetaxel plu cisplatin japanes patient advanc nonsmallcel lung cancer tcog cat trial ann oncol usag tcog_a descript kaplanmei digit data tcog figur pmid report sampl size primari endpoint os lung cancer exampl summarytcog_a kmplottcog_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameelda_a aliaselda_a titleelda figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm cmf wdocetaxel cr sourc perron f nuzzo f di rella f et al weekli docetaxel versu cmf adjuv chemotherapi older women earli breast cancer final result random phase iii elda trial ann oncol usag elda_a descript kaplanmei digit data elda figur pmid report sampl size primari endpoint df breast cancer exampl summaryelda_a kmplotelda_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameea_c aliasea_c titleea figur c format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm p p cr sourc sparano ja zhao f martino et al longterm followup e phase iii trial evalu role taxan schedul oper breast cancer j clin oncol usag ea_c descript kaplanmei digit data ea figur c pmid report sampl size primari endpoint df breast cancer exampl summaryea_c kmplotea_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namechhipa_b aliaschhipa_b titlechhipa figur b format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm gy gy cr sourc dearnaley syndiku mossop h et al convent versu hypofraction highdos intensitymodul radiotherapi prostat cancer year outcom randomis noninferior phase chhip trial lancet oncol usag chhipa_b descript kaplanmei digit data chhipa figur b pmid report sampl size primari endpoint brf prostat cancer exampl summarychhipa_b kmplotchhipa_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameimelda_a aliasimelda_a titleimelda figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm bevacizumab bevacizumab_capecitabin cr sourc gligorov j doval bine j et al mainten capecitabin bevacizumab versu bevacizumab alon initi firstlin bevacizumab docetaxel patient herneg metastat breast cancer imelda randomis openlabel phase trial lancet oncol usag imelda_a descript kaplanmei digit data imelda figur pmid report sampl size primari endpoint pf breast cancer exampl summaryimelda_a kmplotimelda_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameact_c aliasact_c titleact figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm wt_b wt_be cr sourc hagman h fr√∂din je berglund √• et al random studi krasguid mainten therapi bevacizumab erlotinib metronom capecitabin firstlin induct treatment metastat colorect cancer nordic act trial ann oncol usag act_c descript kaplanmei digit data act figur c pmid report sampl size primari endpoint pfsmo colorect cancer exampl summaryact_c kmplotact_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namenct_c aliasnct_c titlenct figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm gc gci cr sourc oshaughnessi j schwartzberg l danso et al phase iii studi iniparib plu gemcitabin carboplatin versu gemcitabin carboplatin patient metastat tripleneg breast cancer j clin oncol usag nct_c descript kaplanmei digit data nct figur c pmid report sampl size primari endpoint ospf breast cancer exampl summarynct_c kmplotnct_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namemainsail_a aliasmainsail_a titlemainsail figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm lenolidomid placebo cr sourc petrylak dp vogelzang nj budnik n et al docetaxel prednison without lenalidomid chemotherapyna patient metastat castrationresist prostat cancer mainsail randomis doubleblind placebocontrol phase trial lancet oncol usag mainsail_a descript kaplanmei digit data mainsail figur pmid report sampl size primari endpoint os prostat cancer exampl summarymainsail_a kmplotmainsail_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameattention_b aliasattention_b titleattent figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm placebo tivantinib cr sourc yoshioka h azuma k yamamoto n et al random doubleblind placebocontrol phase iii trial erlotinib without cmet inhibitor tivantinib arq asian patient previous treat stage iiibiv nonsquam nonsmallcel lung cancer harbor wildtyp epiderm growth factor receptor attent studi ann oncol usag attention_b descript kaplanmei digit data attent figur b pmid report sampl size primari endpoint os lung cancer exampl summaryattention_b kmplotattention_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameprose_b aliasprose_b titlepros figur b format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm chemo erlotinib cr sourc gregorc v novello lazzari c et al predict valu proteom signatur patient nonsmallcel lung cancer treat secondlin erlotinib chemotherapi prose biomarkerstratifi randomis phase trial lancet oncol usag prose_b descript kaplanmei digit data prose figur b pmid report sampl size primari endpoint os lung cancer exampl summaryprose_b kmplotprose_b keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nametextsoft_d aliastextsoft_d titletextsoft figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm exemestane_o tamoxifen_o cr sourc pagani regan mm walley ba et al adjuv exemestan ovarian suppress premenopaus breast cancer n engl j med usag textsoft_d descript kaplanmei digit data textsoft figur pmid report sampl size primari endpoint df breast cancer exampl summarytextsoft_d kmplottextsoft_d keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameercc_c aliasercc_c titleercc figur c format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm cisplatin paclitaxel_gemcitabin cr sourc lee sm falzon blackhal f et al random prospect biomark trial ercc compar platinum nonplatinum therapi advanc nonsmallcel lung cancer ercc trial et j clin oncol usag ercc_c descript kaplanmei digit data ercc figur c pmid report sampl size primari endpoint os lung cancer exampl summaryercc_c kmplotercc_c keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameoptimal_ aliasoptimal_ titleoptim figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm erlotinib gem_carboplatin cr sourc zhou c wu yl chen g et al final overal surviv result randomis phase iii studi erlotinib versu chemotherapi firstlin treatment egfr mutationposit advanc nonsmallcel lung cancer optim ctong ann oncol usag optimal_ descript kaplanmei digit data optim figur pmid report sampl size primari endpoint pf lung cancer exampl summaryoptimal_ kmplotoptimal_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namesmart_ aliassmart_ titlesmart figur format data frame observ variabl tabularll tab codetim tab event time day cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm deferred_rt immediate_rt cr sourc clive ao taylor h dobson l et al prophylact radiotherapi prevent proceduretract metastas surgic largebor pleural procedur malign pleural mesothelioma smart multicentr openlabel phase randomis control trial lancet oncol usag smart_ descript kaplanmei digit data smart figur pmid report sampl size primari endpoint ptmincid lung cancer exampl summarysmart_ kmplotsmart_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameec_a aliasec_a titleec figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab df event indic code event code event cr tab codearm tab treatment arm p cr sourc sparano ja zhao f martino et al longterm followup e phase iii trial evalu role taxan schedul oper breast cancer j clin oncol usag ec_a descript kaplanmei digit data ec figur pmid report sampl size primari endpoint df breast cancer exampl summaryec_a kmplotec_a keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata namesakk_ aliassakk_ titlesakk figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm bev no_bev cr sourc koeberl bettich dc von moo r et al bevacizumab continu versu continu firstlin chemotherapi plu bevacizumab patient metastat colorect cancer random phase iii noninferior trial sakk ann oncol usag sakk_ descript kaplanmei digit data sakk figur pmid report sampl size primari endpoint ttp colorect cancer exampl summarysakk_ kmplotsakk_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameca_ aliasca_ titleca figur format data frame observ variabl tabularll tab codetim tab event time year cr tab codeev tab os event indic code event code event cr tab codearm tab treatment arm b cr sourc love rr laudico av van dinh n et al time adjuv surgic oophorectomi menstrual cycl diseasefre overal surviv premenopaus women oper breast cancer j natl cancer inst djv usag ca_ descript kaplanmei digit data ca figur pmid report sampl size primari endpoint df breast cancer exampl summaryca_ kmplotca_ keyworddataset gener roxygen edit hand pleas edit document rdatar doctypedata nameturandot_ aliasturandot_ titleturandot figur format data frame observ variabl tabularll tab codetim tab event time month cr tab codeev tab pf event indic code event code event cr tab codearm tab treatment arm bev_capecitabin bev_paclitaxel cr sourc zielinski c l√°ng inbar et al bevacizumab plu paclitaxel versu bevacizumab plu capecitabin firstlin treatment herneg metastat breast cancer turandot primari endpoint result randomis openlabel noninferior phase trial lancet oncol usag turandot_ descript kaplanmei digit data turandot figur pmid report sampl size primari endpoint os breast cancer exampl summaryturandot_ kmplotturandot_ keyworddataset